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Abstract 
Covalent modification of histones is an important factor in the regulation of 
the chromatin structure implicated in DNA replication, repair, recombination, 
and transcription, as well as in RNA processing. In recent years, histone 
methylation has emerged as one of the key modifications regulating 
chromatin function. However, the mechanisms involved are complex and 
not well understood. Histone 3 lysine 4 (H3K4) methylation is deposited by 
a family of histone H3K4 methyltransferases (HMTs) that share a conserved 
SET domain. In mammalian cells, six family members have been 
characterized: Setd1a and Setd1b (the mammalian orthologs of yeast Set1) 
and four Mixed lineage leukemia (Mll) family HMTs, which share limited 
similarity with yeast Set1 beyond the SET domain. Several studies 
demonstrated that the H3K4 methyltransferases exist as multiprotein 
complexes. To functionally dissect H3K4 methyltransferase complexes, 
GFP tagging of the core subunit Ash2l and the complex-specific subunits 
Cxxc1 and Wdr82 (Setd1a/b complexes) Men1 (Mll1/2 complexes), and Ptip 
(Mll3/Mll4 complexes), was used. The fusion proteins were successfully 
expressed in mouse embryonic stem cells (ES cells), analyzed by confocal 
microscopy, Mass Spectrometry (MS) and ChIP-seq. Ptip was the only 
subunit able to bind mitotic chromatin. Additionally, both Ptip and Wdr82 
were found to associate with cell cycle regulators, suggesting a possible 
role of the two proteins or respective complexes in cell cycle regulation. 
Mass Spectrometry revealed that Wdr82 and Ptip interact with members of 
the PAF complex, and ChIP-seq showed that Wdr82, Cxxc1 and Ptip 
positively modulate pluripotency genes. Thus, Setd1a/b and Mll3/4 
complexes might act together in the regulation of embryonic stem cells 
identity. Protein pull downs identified at least one new Setd1a/b interactor, 
Bod1l that is orthologous to the yeast protein Sgh1, a component of the 
Set1C complex. Furthermore, our MS and ChIP-seq data suggested that 
only Mll2 complex binds to bivalent promoters, wheras Mll2 and Setd1a 
complexes might function together in a set of promoters.  
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1. Introduction 
 
1.1. Epigenetics 
 
Genomic DNA is the ultimate template of our heredity. Despite the 
excitement over the human genome, many challenges remain in 
understanding the regulation and transduction of genetic information.  
DNA alone does not provide the full range of information that finally results 
in a complex eukaryotic organism. All somatic cells obviously contain the 
same genetic information, but each cell type has a specific gene expression 
pattern. There are several layers of regulation of gene expression. One way 
that genes are regulated is through the remodeling and modification of 
chromatin.  
The term ‘‘epigenetic’’ refers to the information contained in chromatin, 
other than the actual DNA sequence, that defines a heritable specific gene 
expression pattern. Epigenetically controlled genes are activated or 
repressed without any change in DNA. Perturbation of epigenetic balances 
may lead to alterations in gene expression, resulting in cellular 
transformation and malignant outgrowth.  
 
1.2. Chromatin structure 
 
In all eukaryotes, DNA is compacted into the nucleus as chromatin. The 
traditional outlook is that chromatin is required for packing of the 1 m 
length of the human genome DNA into the 10 μm diameter average size 
human nucleus. However, our view on the function of chromatin has 
become broader and more dynamic than just that of a DNA-packaging 
device. Chromatin represents an additional level of regulation for all DNA 
metabolic processes (replication, repair and gene expression), working as a 
platform where biological signals integrate and molecular responses take 
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place. 
The structural unit of chromatin is the nucleosome, which consists of 146 bp 
of DNA wrapped around an octamer of very basic proteins called histones. 
Each nucleosome core consists of two copies of each of the histones: H2A, 
H2B, H3 and H4. These evolutionarily conserved proteins have a globular 
C-terminal domain critical to nucleosome formation and a flexible and 
unstructured N-terminal tail that protrudes from the nucleosome core. It 
remains unclear how nucleosomal arrays containing linker histone (H1) then 
twist and fold this chromatin fiber into increasingly more compacted 
filaments leading to defined higher order structures (Chodaparambil et al., 
2006).  
Nucleosomes assemble on an 11 nm filament array known as beads on a 
string, which undergoes a series of wrapping and compacting events as 
cells progress from interphase to metaphase, culminating with the 
completely condensed chromosome during metaphase. Besides this 
generic organization, local chromosomal domains present different levels of 
structure: heterochromatin was originally identified cytogenetically as the 
portion of the genome that remains condensed after the transition from 
metaphase to interphase. These regions correspond to telomeres and 
pericentric chromosomal areas and generally localize attached to the 
perinuclear compartment. Heterochromatic areas tend to be rich in 
repetitive sequences, low in gene content (although some genes are 
present), transcriptionally silent or showing a variegating phenotype and 
typically replicate late. Euchromatin on the other hand may be considered 
as the rest of the genome, which de-condenses during interphase, contains 
most of the genes, is active or proficient for transcription and replicates 
early. In addition, chromatin organization may change transiently in local 
areas of the genome as a response to cellular stimuli and/or differentiation 
programs (Bassett et al., 2009). 
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1.3. Chromatin remodeling 
 
The cell has developed mechanisms to modify the chromatin in a 
temporal/spatial manner and to ensure the maintenance of such an 
organization through mitotic and meiotic cell division: 
a. Post-translational covalent modifications of the N-terminal histone tails 
within a nucleosome can either facilitate or reduce the association of DNA 
repair proteins and transcription factors with chromatin (Santos-Rosa and 
Caldas, 2005).  
b. ATP-dependent chromatin remodeling factors twist and slide nucleosomes, 
exposing or occluding local DNA areas to interactions with replication, DNA 
repair and transcription factors (Flaus et al., 2004). 
c. Methylation at the Cytosine-5 position of cytosine residues present in CpG 
dinucleotides by DNA methyltransferases (DNMTs) facilitates static long-
term gene silencing and confers genome stability through repression of 
transposons and repetitive DNA elements. This is achieved through 
recognition of methyl-cytosine by specific methyl-DNA binding proteins that 
recruit transcriptional repressor complexes and histone modifying activities 
(Scarano et al., 2005). 
d. Canonical histones in a nucleosome can be replaced by histone variants 
through a DNA-replication independent deposition mechanism (Gallet and 
Almouzni, 2010). Histone variants harbor distinct information to respond to 
DNA damage conditions or to override an established gene expression 
stage (Kamakaka et al., 2005). 
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1.4. Post-translational histone modifications 
 
A variety of post-translational modifications occur on the amino terminal tail, 
as well as on the residues located at exposed sites within the globular 
domain of the histones (Couture and Trievel, 2006). These post-
translational modifications include phosphorylation, acetylation, 
ubiquitination, methylation and SUMOylation (Fig. 1). Such modifications on 
histones can create or stabilize binding sites for regulatory proteins, like 
transcription factors, proteins involved in chromatin condensation or DNA 
repair.  
Histone modifications may also have the opposite effect, by disrupting or 
occluding chromatin-binding sites (Lee et al., 2010). 
 
 
Fig. 1. Post-translational modifications on the histone tails. Lysine 9, Lysine 14, Lysine 23 and 
Lysine 27 in the H3 tail and Lysine 12 and Lysine 20 in H4 can be either acetylated or methylated. 
 
 
Accordingly, there are modifications that co-exist and work sequentially in a 
cooperative manner but are incompatible with others in the same 
nucleosome. That is the case for methylation of histone H3 lysine 4 (H3K4), 
Santos-Rosa and Caldas, 2005 
 5 
acetylation of histone H3 lysine 14 (H3K14) and phosphorylation of histone 
H3 serine 10 (H3S10). All these covalent modifications are involved in 
transcription activation and are incompatible with the generally inhibitory H3 
lysine 9 methylation (Lee et al., 2010; Fig. 2).  
 
 
 
Fig. 2. Interaction between different post-translational modifications. ‘‘Compatible’’ 
modifications (those which facilitate other modifications to occur and/or can co-exist) are represented 
by green arrows. ‘‘Incompatible’’ modifications (those which negatively affect other modification 
and/or can not co-exist) are shown in red. 
 
Furthermore, the role of a particular modification in transcriptional signaling 
may also be influenced by the degree and stability of the modification. 
Lysine residues may be modified with one, two, or three methyl groups, and 
the ‘‘status’’ of histone methylation determines if transcription of certain 
genes is activated or repressed (Grewal et al., 2004). 
Distinct histone modifications, on one or more tails, act sequentially or in 
combination to form a ‘‘histone code’’ that is read by proteins containing 
specific interacting domains: bromodomain and chromodomain. 
Bromodomains are small protein domains that form an extensive family 
(Jeanmougin et al., 1997) and mainly act as acetyl-lysine binding domains 
Santos-Rosa and Caldas, 2005 
 
 
 
 
 
 
 
 
M: Methylation 
A: Acetilation 
P: Phosphorylation 
U: Ubiquitination 
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on acetylated histone tails (Hudson et al., 2000). The highly conserved 
residues of bromodomain proteins tend to define the domain binding site 
proteins (de la Cruz et al., 2005). Bromodomain is charachterized by a 110 
aminoacid unit and it is widely distributed among the different enzymes that 
acetylate, methylate or remodel chromatin. The mode of recognition of 
acetyl-lysine by the Bromo domain is similar to that of acetyl-CoA by histone 
acetyltransferases, though the bromodomain is the only domain known that 
interacts with acetylated lysine containing peptides. Recognition of acetyl-
lysine by bromodomain proteins is not limited to histones. For example, the 
bromodomain of CREB binding protein transcriptional coactivator (CBP) 
allows for recognition of p53 with acetylated Lys382. The interaction 
between the bromodomain and acetyl-p53 follows DNA damage and 
promotes p53-induced transcriptional activation of the CDK inhibitor p21 
and cell cycle arrest (Eichenbaum et al., 2010). 
The Chromodomain is defined as a 30-70 aminoacid residue protein 
module found in many proteins involved in the assembly of protein 
complexes on chromatin, such as the transcriptional repressors HP1 and 
Polycomb (Pc), and the human retinoblastoma binding protein (RBP-1). 
This domain was first described in Drosophila modifiers of variegation 
proteins that modify chromatin into condensed heterochromatin, a 
cytologically visible region of repressed gene expression (Paro and 
Hogness, 1991). Chromodomains promote protein binding to methylated 
lysines in the tail region of histone H3. Chromodomains can function 
individually or in tandem, as with CHD1, to recognize specific methylated 
Histone tails. Chromodomain-like motifs are present in HP1 and other 
proteins; in particular this "chromo shadow domain” occurs in proteins that 
also have an N-terminally located chromo domain (Aasland and Stewart 
1995). Bromo- and chromodomain proteins are the effectors that initiate 
downstream biological responses such as chromosome condensation, DNA 
repair or transcription activation/repression (De la Cruz et al., 2005).  
Examples of recruitment of chromo- and bromodomain containing proteins, 
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leading to different transcriptional read outs are shown in Figure 3. 
 
  
 
Fig. 3. Recruitment of bromo- and chromodomain containing proteins by histone 
modifications. (a) Establishment of silent chromatin (heterochromatin) by lysine 9 H3 methylation: 
(1) SuV39H1 methylates lysine 9 H3. (2) Methylated Lysine 9 recruits the heterochromatin protein 
HP1 in physical association with SuV39H1. (3) Methylation of adjacent nucleosomes by SuV39H1 
causes the spreading of the heterochromatin. (b) Establishment of transcriptionally active chromatin 
by lysine 4 H3 methylation: (1) Set1p methylates lysine 4 H3. (2) Methylated lysine 4 recruits the 
chromatin remodeling factor Chd1p in physical association with histone acetyltransferases (HATs). 
(3) Acetylation of lysine residues prevents repressive modifications from occurring and recruits 
transcription activators. (c) Establishment of transcriptionally active chromatin by lysine acetylation: 
(1) GCN5 acetylates several residues within histones H3 and H4. (2) Acetylated lysines recruit the 
chromatin remodeling complex SWI/SNF. (3) SWI/SNF, via its ATPase activity, displaces and twists 
nucleosomes exposing DNA areas for interaction with the transcription machinery. 
 
Thus, although the basic composition of the nucleosome may be the same 
over long stretches of chromatin, the specific pattern of modifications on 
nucleosomes creates local structural and functional diversity delimiting 
chromatin subdomains. 
The molecular basis for how the epigenetic information carried in histone 
tail modifications is memorized is unknown. Interestingly, biochemical data 
Santos-Rosa and Caldas, 2005
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have suggested histones H3 and H4 are deposited into nascent 
nucleosomes as heterodimers (Tagami et al., 2004). This opens the 
possibility that the existing epigenetically coded H3/H4 dimers are divided 
on the two daughter strands, thereby forming the basis for an epigenetic 
memory imprint. 
 
1.5. Programming of gene expression by Polycomb 
group (PcG) proteins and Trithorax group (TrxG) proteins 
 
The regulation of chromatin structure, which includes nucleosome 
remodeling and post-translational modification of histone proteins, is 
necessary for the establishment and maintenance of heritable gene 
expression patterns during development (Dunn and Kingston 2007; 
Kouzarides 2007). 
Trithorax group (TrxG) and Polycomb group (PcG) protein complexes are 
key regulators of chromatin structure that are necessary for maintenance of 
the ES cell gene expression program and are required for segmental 
identity in the developing embryo (Schuettengruber et al., 2007).  
Polycomb group (PcG) proteins were first discovered in the fruit fly 
Drosophila melanogaster. In Drosophila as well as in other organisms, the 
family of PcG proteins is required for the control of body segmentation by 
preventing inappropriate expression of Hox genes. Later work 
demonstrated that PcG proteins are master regulators of so-called genomic 
programs – owing to their ability to maintain genes in an active or repressed 
state, dependent on the differentiation status over many cell divisions 
(Schwartz and Pirrotta, 2007). It appears that, in any particular cell type, 
PcG proteins repress all alternative genetic programs that are not needed. 
Consequently, PcG proteins are required to maintain stem cell identity, and 
they do this by suppressing key regulators of differentiation pathways 
(Boyer et al., 2006). 
PcG proteins assemble as high molecular weight complexes. They were 
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initially purified from Drosophila, but homologous complexes were later 
isolated in other organisms. Drosophila has three different PcG complexes 
– Polycomb repressive complex 1 (PRC1), Polycomb repressive complex 2 
(PRC2) and Pleiohomeotic repressive complex (PhoRC). PRC2 is thought 
to be involved in the initiation of gene silencing, whereas PRC1 is 
implicated in the stable maintenance of gene repression. The function of 
PhoRC is not well defined.  
The PcG protein complex PRC2 catalyzes H3K27me3, which contributes to 
repression of genes encoding key developmental regulators. Disruption of 
PcG function in ES cells leads to derepression of these developmental 
genes, alteration of the ES cell transcriptional program, and a loss of the ES 
cell state (Boyer et al., 2006).  
Trithorax (Trx) was discovered as a spontaneous mutation that gave a 
partial transformation of halteres, a pair of lobe-like projections that lie 
behind the wings, into wings (Ingham and Whittle, 1980). 
Further characterization revealed leg transformations as well, and in a few 
cases, the appearance of a supernumerary pair of wing-like structures on 
the thoracic segment ahead of the normal wing position, resulting in three 
sets of wings (hence the name “trithorax”).  
The phenotypes of the original Trx allele included transformations of 
posterior abdominal segments to the appearance of more anterior 
segments, which, together with the haltere-to-wing transformation, 
resembles loss-of-function mutations in the Bithorax complex, one of the 
two clusters of homeotic (Hox) genes in the Drosophila melanogaster 
genome. This implicated Trx as a positive regulator of Hox gene function. 
Subsequent cloning and molecular analysis established that the Trx protein 
shares a common motif, the eponymous Su(var)3-9/Enhancer of 
zeste/trithorax (SET) domain, with other epigenetic regulators. 
TrxG complexes catalyze histone H3K4 trimethylation (H3K4me3) in 
proximity to promoters of genes that experience transcription initiation by 
RNA polymerase II. Since most genes undergo some level of transcription 
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initiation, most promoters are occupied by nucleosomes with histone 
H3K4me3 (Guenther et al., 2007).  
In ES cells, genes encoding lineage-specific developmental regulators 
contain nucleosomes with both H3K4me3 and H3K27me3 modifications, 
and have thus been called ‘‘bivalent’’ (Bernstein et al., 2006). These genes 
apparently experience some level of transcription initiation, and therefore 
TrxG-mediated histone H3K4 methylation, but are silenced by PcG 
complexes, which may occur through repression of transcription elongation 
(Stock et al., 2007). 
 
1.6. The mammalian Trx-related proteins 
 
To better understand the molecular function of Trx, the yeast Set1 protein 
was identified as the Trx homolog in yeast (Roguev et al., 2001; Roguev et 
al., 2003; Nislow et al., 1997), and was subsequently purified in a 
macromolecular complex named COMPASS (Complex Associated with 
Set1; Miller et al., 2001). It was demonstrated that COMPASS has H3K4 
methylase activity (Roguev et al., 2001; Krogan et al., 2002). Subsequently, 
it was shown that the Drosophila and mammalian H3K4 methyltransferases 
also exist in COMPASS-like complexes capable of methylating H3K4 
(Shilatifard, 2008).  
The mammalian genome contains genes encoding six Trx-related proteins: 
Setd1a and Setd1b, Mll1, Mll2, Mll3, and Mll4. The high conservation and 
multiplicity of H3K4 methyltransferases (Fig. 4) suggests that they have 
crucial and distinct functions in the cell, although their detailed mechanisms 
of action are largely unknown.  
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Fig. 4. Domain structure of animal H3K4 methyltransferases. AT-hook is a DNA-binding domain. 
Bromodomains (BROMO) are involved in the recognition of acetylated lysine residues in histone tails. 
CXXC-zf is a Zn-finger domain involved in protein–protein interactions. FYRC and FYRN domains 
are involved in heterodimerization between MllN and MllC terminal fragments. High-mobility group 
(HMG) domains are involved in binding DNA with low sequence specificity. LXXLL domains (also 
known as the NR box) are involved in interaction with nuclear receptors (NR). Plant homodomain 
(PHD) and RING fingers are usually involved in protein–protein interactions. The SET domain is 
responsible for histone lysine methylation. Taspase proteolytic sites are represented as arrows. 
 
 
Recent studies have demonstrated that H3K4 methyltransferases are key 
epigenetic regulators of diverse gene types associated with cell-cycle 
regulation, embryogenesis and development. H3K4 methyltransferases also 
interact with nuclear receptors (NR) and coordinate hormone-dependent 
gene regulation, suggesting a crucial role in reproduction, organogenesis 
and disease (Lee et al., 2008).  
It is well known that H3K4 methyltransferases are often rearranged, 
amplified or deleted in different types of cancer (Marschalek, 2010). H3K4 
methyltransferases are master regulators of Hox genes, which are key 
players in embryogenesis and development (Guenther et al., 2005). 
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1.7. Shared and unique H3K4 methyltransferase complex 
components 
 
In yeast, several studies demonstrated that the only histone 
methyltransferase Set1/COMPASS exists as a multiprotein complex (Dehe´ 
et al., 2006; Miller et al., 2001; Takahashi and Shilatifard, 2010). Because of 
their importance in gene regulation and disease, the mammalian Set1 
counterparts have been isolated from human and murine cells and their 
protein-protein interaction profiles and enzymatic activities have been 
characterized in detail (Table 1). 
 
  
 
Table 1. Subunit composition for yeast COMPASS and its mammalian homologs Setd1a/b and 
MLL1-4 complexes.  
 
It has been shown that the yeast Set1C/COMPASS and the mammalian  
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Mll1, Mll2, Mll3, Mll4, Setd1a and Setd1b share several subunits including 
Ash2l, Wdr5, Rbbp5 and Dpy30 (Dehé et al., 2006; Dou et al., 2006).  
In addition to the core components, Mlls interact with various unique 
components including chromatin-remodeling factors, mRNA-processing 
factors and nuclear hormone receptors. For instance, Wdr82 and Cxxc1, 
are found only in COMPASS and Setd1a/b complexes; Men1 is a specific 
component of Mll1/2 complexes; Ptip is a unique subunit of Mll3/4 
complexes. 
Ash2l, the absent small homeotic discs 2-like (Ash2L) protein, functions at 
the molecular level along with WDR5 and RbBP5 to form a submodule of 
the Setd1a, Setd1b, and Mll methyltransferase complexes. Interestingly, the 
Ash2l, Rbbp5, Wdr5, Dpy30 submodule was shown to possess an intrinsic 
methyltransferase activity toward histone H3K4 in vitro independent of Mll, 
although none of these proteins contain a catalytic SET domain (Patel et al., 
2009). 
CXXC finger protein 1 is a component of the euchromatic Setd1a and 
Setd1b histone H3K4 methyltransferase complexes, and is a critical 
regulator of histone methylation, cytosine methylation, cellular 
differentiation, and vertebrate development. Mouse embryonic stem (ES) 
cells lacking Cxxc1 are viable but show increased levels of global histone 
H3K4 methylation, suggesting that Cxxc1 functions to inhibit or restrict the 
activity of the Setd1A histone H3K4 methyltransferase complex (Tate et al., 
2010). 
Homozygous deletion of Men1 (the murine equivalent of human MEN1) is 
lethal, and the embryos die at the mid-gestation with defects in the neural 
tube, the liver and the heart. Men1 was first demonstrated to be part of 
protein complexes that are involved in erasing the acetyl mark from 
histones (Kim et al., 2003). Additionally, Men1 has been shown before to be 
involved in repression of JunD- and NF-kB-dependent transcription 
(Agarwal et al., 1999; Heppner et al., 2001) and in the attenuation of 
transcription of the telomerase (hTERT) gene. Consequently, loss of Men1 
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could contribute to the development of endocrine tumour cells. The human 
MEN1 is known to cause a variety of endocrine neoplasms, including 
parathyroid hyperplasia and adenomas, pituitary adenomas and pancreatic 
islet cell tumors. More recently, immunoprecipitation experiments 
demonstrated that Men1 is part of Mll protein-containing complexes through 
a direct interaction with Mll proteins (Huges et al., 2004). 
Although Ptip associates with Mll-containing H3K4 methyltransferase 
complexes, it is not required for their enzymatic activity (Cho et al., 2007). 
Therefore, the available data strongly support a model in which Ptip 
interacts with transcription factors that bind directly to promoters, such as 
Pax2, and facilitates the recruitment of H3K4 methyltransferase complexes, 
thereby activating transcription (Patel et al., 2007). Disruption of murine Ptip 
has shown that it has a crucial role in the preservation of genome stability 
by preventing double strand breaks (Muñoz and Rouse, 2009). Ptip 
promotes specific chromatin changes that control the accessibility of the IgH 
locus to class switch recombination in lymphocytes (Daniel et al., 2010). 
Ptip -/- ES cell lines show lower levels of H3K4 methylation, including at the 
Oct4 and Sox2 promoters, reduced Oct4 protein and mRNA expression, 
and spontaneous differentiation toward the trophectoderm lineage (Kim et 
al., 2009).  
Wdr82 (homologous to yeast Swd2) has only been detected in 
Setd1a/Setd1b complexes and not in other mammalian Set1-like histone 
methyltransferase complexes. As a non-catalytic subunit in the complex, 
Wdr82 plays a role in both site recognition and maintenance of the stability 
of the complex (Lee and Skalnik, 2008). Although it has been shown that a 
defect in Wdr82 causes dysfunction of Setd1a/Setd1b and results in loss of 
H3K4me3 in human cell lines, the exact role of Wdr82 in the 
methyltransferase complex during early embryonic development is not 
clear. 
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1.8. Embryonic stem cells, protein tagging and 
recombineering as a platform for functional genomics and 
proteomics 
 
Once they developed, many adult tissues are not regenerated. Most 
neurons and cardiomyocytes, for instance, cannot be replaced if they are 
damaged or lost. There are several populations of cells, however, that are 
constantly dying and being replaced. Each day, we lose and replace about 
1.5 grams of skin cells and about 1011 red blood cells. The skin cells are 
sloughed off, and the red blood cells are removed by the spleen. 
Replacements for these cells come from populations of stem cells. There 
are many types of stem cells. All share the characteristics of being able to 
self-renew and to give rise to differentiated progeny. Over the last decades, 
great excitement has been generated by the prospect of being able to 
exploit these properties for the repair, improvement, and/or replacement of 
damaged organs. Adult somatic stem cells are found in the majority of 
organs and tissues in adult organisms, and are thought to function in long-
term tissue maintenance and/or repair. In contrast, embryonic stem cells 
are derived only from the embryo’s blastocyst and are unique in their ability 
to be maintained in vitro in a pluripotent state, i.e., capable of recapitulating 
all three germ layers and an entire organism.
In general pluripotent stem cells can be derived: (i) from the inner cell mass 
(ICM) of pre-implantation mouse or human blastocysts (ES cells); (ii) from 
the epiblast of early postimplantation (embryonic day 5.5–6.5) mouse 
embryos or by differentation of ES cells with Activin A and Fgf2 (EpiSCs- 
Epiblast-derived Stem Cells); (iii) by reprogramming of differentiated cells to 
induced pluripotent stem cells (iPSCs); (iv) by somatic cell nucleus transfer 
(Fig. 5).  
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Fig 5. Isolation of pluripotent stem cells. (A) After isolation, typically from the inner cell mass of the 
blastocyst made by means of in vitro fertilization, ES cells are expanded in culture.  (B) Somatic cell 
nuclear transfer consists of injecting the nucleus from a somatic cell into an enucleated oocyte, 
followed by activation stimuli. The resulting embryo can be used to generate an ES cell line (C) 
iPSCs are generated from differentiated cells that have been reprogrammed to acquire a pluripotent 
state through overexpression of the key transcription factors Oct4, Sox2, and either c-Myc and Klf4 or 
Nanog and Lin28. Overexpression can be achieved with viral vectors or proteins with or without 
histone-modifying chemicals. Once they are undifferentiated, they can be grown in culture like ES 
cells. (D) EpiSCs can be obtained from the epiblast of early postimplantation (embryonic day 5.5–6.5) 
mouse embryos or derived from ES cells by differentation with Activin A and Fgf2. 
  
The mechanisms by which stem cells are able to execute lineage-specific 
gene expression programs comprise, in part, a network of transcription 
factors and chromatin regulators. Three transcription factors, Oct4, Sox2, 
and Nanog, cooperate to ensure the self-renewal and pluripotency of ES 
cells (Boyer et al., 2005; Loh et al., 2006). These factors are highly 
expressed in undifferentiated ES cells and physically interact with each 
other in large protein complexes (Wang et al., 2006; van den Berg et al., 
2010). Oct4, Sox2, and Nanog are transcriptionally interconnected and co-
occupy promoters of actively transcribed genes that promote ES cell self-
renewal such as Klf4 and Rex1 (Boyer et al., 2005; Loh et al., 2006; Kim et 
Brignier et al., 2010
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al., 2008). They also occupy genes encoding a large set of developmental 
regulators that are silent in ES cells, but whose expression is associated 
with lineage commitment and cellular differentiation (Boyer et al., 2005; Loh 
et al., 2006). It is well known that transcription factors play essential roles as 
regulators of cell fate by controlling gene expression. While chromatin 
regulation has also emerged as a key mechanism for controlling genome 
organization and function, deciphering its role in development and cell fate 
determination has been less obvious and more complex.  
Embryonic stem cells have become an indispensable tool for investigating 
genetic function both in vitro and, importantly, in vivo. As a model system, 
ES cells have indeed two important advantages:  
(i) Efficient genetic manipulation is amenable (Friel et al., 2006). For 
example homologous recombination between genomic and the exogenous 
DNA (gene targeting) is a very inefficient event, but it takes place in mouse 
ES cells with relatively higher efficiency than it does in other cell types 
(Doetschman et al., 1987; Thomas & Capecchi 1987);  
(ii) Differentiation of ES cells in other cell types has been widely established 
and optimized (Stavridis and Smith, 2003; Boheler et al., 2002; Wei et al., 
2005; Niwa, 2010).  
Alteration of the ES genome includes the generation of tissue or conditional 
knock out allelles by homologous recombination and the production of 
knock in cell lines by transgenesis or gene targeting. These approaches are 
generally used to determine the role of a gene in development or to create 
animal models of disease. Although some genetic modifications are lethal, 
functional genomic studies can still be carried out on the targeted ES cells 
by differentiation in vitro to determine the phenotypic effect in specific cell 
types. On the other hand, differentiated cells show a more diverse protein 
expression pattern than ES cells. For instance, protein complexes in 
differentiated cells may have a distinct subunit composition and dissimilar 
roles to those in ES cells. One of the most useful methods to generate 
specific knock-in is to fuse a tag to a protein of interest.  
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Epitope tagging is a technique in which a known epitope is fused to a 
protein of interest by means of genetic engineering. By choosing an epitope 
for which an antibody is available, the technique makes it possible to detect 
and purify proteins for which no antibody is available. This is especially 
useful for the characterization of newly discovered proteins and proteins of 
low immunogenicity. By selection of the appropriate epitope and antibody 
pair, it is possible to find a combination with properties that are suitable for 
the desired experimental application, such as Western blot analysis, 
immunoprecipitation, immunochemistry, and affinity purification.  
Tags used to improve the production of recombinant proteins can be 
roughly divided into purification and solubility tags. The former are used 
along with affinity binding to allow rapid and efficient purification of proteins, 
while the latter refer to tags that enhance the proper folding and solubility of 
a protein. Multiple tags can be attached on target proteins, allowing for 
improved purification, expression, or tracking. The tandem affinity 
purification (TAP) tag was originally developed to allow for two purification 
steps first on protein A-IgG beads, followed by cleavage of the protein A tag 
and subsequent purification on calmodulin coated beads (Puig et al., 2001). 
The use of tandem tags allows TAP-tagged proteins to be detected and 
purified in native conditions even when expressed at very low levels.TAP 
tagging has been widely used in yeast, providing an almost complete profile 
of the yeast proteome (Gavin et al., 2006; Krogan et al., 2006; Shevchenko 
et al., 2008). Tags can be placed at either the N- or C-terminus of a target 
protein. One advantage of placing a tag on the N-terminal end is that the 
construct can take advantage of efficient translation initiation sites on the 
tag. Solubility tags based on highly expressing proteins such as MBP, Trx, 
and NusA are also more efficient at solubilizing target proteins when 
positioned at the N-terminal end (Sachdev and Chirgwin, 1998), though 
recent highthroughput studies have shown than the MBP tag is still quite 
effective when positioned at the C-terminal end (Dyson et al., 2004). 
Another advantage of placing a tag on the N-terminal site is that the tag can 
 19 
be removed more cleanly, since most endoproteases cut at or near the C-
terminus of their recognition sites. While placing a tag, care should be taken 
to preserve the positioning of any signal sequences or modification sites. 
Sequences at termini of the fusion protein should be examined for effects 
on the stability of the final construct, especially at the N-terminal end, which 
should be inspected for the host cell’s N-end rule degradation signals 
(Bachmair et al., 1986; Wang et al., 2008). It is also useful to examine the 
sequence of the tagged protein for any inadvertently created interaction or 
cleavage sites using motif databases such as PROSITE (Hulo et al., 2008). 
After a protein tag has been used for solubility enhancement or affinity 
purification, it is often useful to remove it for biological and functional 
studies since the tag can potentially interfere with the proper functioning of 
the target protein. Most commercial expression vectors that are used to add 
tags on target proteins also include cleavage sites with specific sequences 
that allow the tag to be removed using recombinant endoproteases (e.g. 
PreScission protease or TEV protease). After the initial affinity purification 
step, the sample can be treated with the endoprotease to cleave off the tag, 
which can subsequently be separated from the target protein by passing the 
sample back on the affinity column and collecting the flowthrough. The 
recombinant endoprotease usually also comes with an affinity tag, allowing 
for its easy removal after the cleavage reaction. Given the success of 
protein tagging for proteomic mapping in yeast, attention has been directed 
towards developing the same approaches for mammalian systems. In the 
course of the development of tagging methods in yeast, it was realized that 
overexpression of tagged proteins generated noisy data whereas 
physiological expression was critical for the quality of the protein interaction 
data (von Mering et al., 2002; Royer et al., 2010). In yeast, physiological 
expression is easily achieved because tagging endogenous genes by gene 
targeting is straightforward. However, gene targeting in mammalian 
systems is, except for mouse embryonic stem cells, laborious or impractical. 
These disadvantages have been bypassed by the development of 
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recombineering (Zhang et al., 1998; Muyrers et al., 1999) and BAC 
transgenesis for tagged protein expression (Muyrers et al., 1999; Poser et 
al., 2008). Unless the gene is too large to be inserted into one BAC, BAC 
transgenes carry all of the endogenous regulatory elements in their natural 
configuration and therefore almost always recapitulate all endogenous 
controls such as cell cycle regulation of transcription, microRNA regulation 
of translation or alternative splicing.  Consequently, protein expression from 
a BAC transgene usually occurs at physiological levels in a copy-dependent 
manner. For tagged protein expression, BAC transgenesis is almost as 
good as the insertion of the tag into the endogenous gene-by-gene 
targeting. The original methods for recombinant DNA production utilize 
restriction enzymes and DNA ligase. Even though the advent of 
oligonucleotide synthesis and PCR greatly expanded technical capacities, 
all these methods suffer from a size limitation because it becomes 
increasingly difficult to achieve a precise product as the DNA engineering 
task becomes larger. A number of years ago we reasoned that methodology 
based on homologous recombination in E.coli would overcome this 
limitation. This led to our discovery that phage recombinase systems from 
either the rac prophage or the closely related  phage Red operon, mediate 
extremely efficient homologous recombination at any chosen position, 
requiring only short homology arms (Zhang et al., 1998; Muyrers et al., 
1999). This DNA engineering methodology is now termed ‘recombineering’ 
(Datsenko & Wanner, 2000; Yu et al., 2000; Murphy et al., 2000; Muyrers et 
al., 2001; Copeland et al., 2001; Court et al., 2002) and comprises a broad 
range of applications including subcloning by gap repair (Zhang et al., 
2000), point mutagenesis in BACs (Muyrers et al., 2000), oligonucleotide-
directed mutagenesis (Ellis et al., 2001), BAC engineering for gene 
targeting (Testa et al., 2003; Valenzuela et al., 2003; Yang and Seed, 2003; 
Wu et al., 2008; Fu et al., 2010), high throughput DNA engineering (Poser 
et al., 2008; Sarov et al., 2006; Skarnes et al., 2010) and a variety of other, 
often complex, applications.  
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2. Aim of this work 
 
Histone H3K4 methyltransferases are very large proteins (Fig. 4), and are 
therefore difficult to handle for downstream applications. As previously 
mentioned each H3K4 methyltransferase complex consists of a variety of 
common proteins plus at least one complex-specific subunit (Table 1). All 
the complex-specific subunits have a smaller molecular weight, and they 
are potentially a great source of information about the complex. 
The overall goal of this thesis is to acquire new and challenging proteomic 
and regulomic data about histone methyltransferases by GFP tagging 
complex-specific components of each complex (Fig. 6). 
GFP has often been used as a marker of gene expression, protein 
localization in living and fixed tissues as well as for protein targeting in intact 
cells and organisms. Monitoring foreign protein expression via GFP fusion 
is also very appealing for bioprocess applications. Many cells, including 
bacterial, fungal, plant, insect and mammalian cells, can efficiently express 
GFP. Several methods and procedures have been developed to create 
proteins fused with a GFP tag (Ciotta et al., 2011; Hofemeister et al., 2011; 
Meima et al., 2007; Peckham et al., 2006). 
One shared (Ash2l) and four complex-specific H3K4 methyltransferase 
subunits (Cxxc1, Men1, Ptip and Wdr82) were used in this work to 
investigate the H3K4 methylation process. 
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Fig. 6. Generation of tagged proteins for system biology. The Tag cassette is inserted by 
recombineering in a BAC vector carrying the gene of interest. A smaller targeting vector is generated 
by subcloning from the modified BAC. The BAC construct is used for transgenesis as well as the 
targeting vector for homologous recombination in E14Tg2a mouse ES cells. Clones selected for the 
stable expression of tagged proteins provide material for fluorescence analysis, protein and 
chromatin immunoprecipitations (ChIP), respectively suitable for Mass Spectrometry and ChIP on 
chip (where a microarray containing genomic DNA is probed with the fluorescent labeled 
immunoprecipitated DNA) or ChIP-sequencing. 
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3. Materials and methods 
 
3.1. General Materials 
 
3.1.1. Chemicals and Reagents 
 
Reagent Company producer 
  
1,4-diazabicyclo[2.2.2]octane (DABCO) Sigma 
4',6-diamidino-2-phenylindole (DAPI) Sigma 
Acrylamide/bis-acrylamide 30% Severn Biotech Ltd. 
Agarose Serva 
Ammonium persulfate (APS) Sigma 
Ampicillin Sigma 
Bacto-Agar Difco 
Bovine serum albumin (BSA) Sigma 
Bromphenolblue Merck 
Chloramphenicol Sigma 
Cold water fish skin gelatin Sigma 
Dimethyl sulfoxide (DMSO) Sigma 
Dithiothreitol (DTT) Sigma 
Ethanol Merck 
Ethidiumbromide Sigma 
Ethylene diamine tetraacetic acid (EDTA) Sigma 
Ethylene glycol tetraacetic acid (EGTA) Sigma 
Formaldehyde 37% Merck 
Gelatine Merck 
Glycerin Merck 
Glycine Merck 
Glycogen Santa Cruz Biotechnology 
Hepes Biomol 
Hydrochloric acid (HCI) Merck 
IgeaPAL 630 Sigma 
Isopropanol Merck 
Kanamycin sulfate Sigma 
L-arabinose Sigma 
Magnesium chloride (MgCI2) Sigma 
Mercaptoethanol Sigma 
Mowiol Sigma 
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N-Dodecanoyl-N-methylglycine sodium salt Sigma 
Phenol (25):chloroform (24): isoamyl alcohol (1) Sigma 
Phosphate buffered saline (PBS) GIBCO Invitrogen 
Potassium Chloride (KCI) Merck 
Protease inhibitor cocktail Roche 
Protein A/G agarose Santa Cruz Biotechnology 
Salmon Sperm DNA Stratagene 
Sarcosyl Sigma 
SDS sample buffer Sigma 
Sodium Bicarbonate (NaHCO3) Merck 
Sodium Chloride (NaCI) Merck 
Sodium dodecyl sulfate (SDS) Serva 
Sodium Hydroxide (NaOH) Merck 
Sodiumdeoxycholate Sigma 
Tetracycline Sigma 
Tetramethylethylenediamine (TEMED) Sigma 
Triton X- 100 Sigma 
Trizma Merck 
TWEEN-20 Sigma 
 
3.1.2. Cell culture media and supplements 
 
Reagent Company producer 
  
DMEM-High Glucose (4500mg/l) with GlutaMax Gibco Invitrogen 
DMSO Hybri-Max Sigma 
ESGRO (LIF) Millipore 
Fetal Calf Serum PAA 
G418 Gibco Invitrogen 
L-Glutamine Gibco Invitrogen 
Lipofectamine LTX Invitrogen 
MEM non-essential aminoacids Gibco Invitrogen 
OPTI MEM with GlutaMax Gibco Invitrogen 
Penicillin/Streptomycin Gibco Invitrogen 
sodium pyruvate Gibco Invitrogen 
Trypsin/EDTA 1x Gibco Invitrogen 
 
3.1.3. Kits 
 
Reagent Company producer 
  
Brilliant II FAST SYBR® QPCR Kit Agilent 
LongAmp kit NEB 
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NucleoBond BAC 100 Clontech 
Plasmid Purification Kit Qiagen 
SuperSignal West Pico substrate Kit Pierce 
Taq DNA polymerase kit 5 Prime 
Lipofectamine LTX PLUS Invitrogen 
MSB Spin PCRapace Invitek 
Phusion® High-Fidelity PCR Kit Finnzymes 
Phusion® Flash High-Fidelity PCR Kit Finnzymes 
 
3.1.4. Restriction endonucleases 
  
Enzyme Company producer 
  
EcoRI NEB 
EcoRV NEB 
HindIII NEB 
HpaI NEB 
NcoI NEB 
NdeI NEB 
NheI NEB 
SacII NEB 
SalI NEB 
  
 
3.1.5. Other reagents (Markers, nucleotides, etc) 
  
Reagent Company producer 
  
Proteinase K Merck 
dNTP set NEB 
1 kb DNA ladder NEB 
100 bp DNA ladder NEB 
Prestained Protein Marker, broad range (7-175 
kDa) 
NEB 
Colorplus Prestained Protein Marker, broad 
range (10-230 kDa) 
NEB 
 
3.1.6. Antibodies 
  
Primary Antibodies  
  
Ash2l anti-Ash2l, rabbit polyclonal [Bethyl Laboratories] 
eGFP anti-GFP, goat polyclonal [MPI-CBG, Dresden] 
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Secondary Antibodies  
  
Horseradish peroxidase conjugated stabilized rabbit anti-goat IgG [Pierce] 
Horseradish peroxidase conjugated stabilized goat anti -rabbit IgG [Pierce] 
 
3.1.7. Plasmids 
 
pR6K-2Ty1-2PreS-eGFP-b-actin-em7-neo 
pR6K-2Ty1-2PreS-eGFP-PGK-em7-neo 
pR6K-2Ty1-SBP-PreS-eGFP-IRES-neo 
pR6K-mVenus-T2A-gb3-neo 
pSC101-BAD-Red A 
 
 
3.1.8. Synthetic oligonucleotides  
  
Sequence (5'-3') 
  
Chromatin IP  
  
BRCA1 promoter forward AAATGGCGGTTTGCTTATTG 
BRCA1 promoter reverse CGTCCTCTGGTGGATGTTTT 
Chromosome 9 extragenic region 
forward TGGCAGCTTGTGTTGTTAGA 
Chromosome 9 extragenic region 
reverse CCACTATGGTGTCAGGAAGG 
ENO3 promoter forward AGACCCTCCCATCAGAAACC 
ENO3 promoter reverse CGTGTACCCCCTTCTCAAAA 
MAGOHB promoter forward CCCTTATGCCCGACGTAGTA 
MAGOHB promoter reverse GGGGTCTCTTGCTTCCTCTT 
  
  
Long Range PCR  
  
5' Ash2l forward TTTCAGGCATAGCAACAAAATTA 
3' Ash2l reverse AGCCTGGTCTACAGAGTGAGCT 
5' Cxxc1 forward CTGGCATCCCATTGATAAGC 
3' Cxxc1 reverse TGTGGTCCTCCCTTCTTCCT 
5' Men1 forward GCTCACCAAAATCCTTCTGC 
3' Men1 reverse AAGAGGAGACGGGGTGATGT 
5' Ptip forward TTGGCTCTGTCCCAAAATTC 
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3' Ptip reverse TTGCTAAAGCAGGGACCAGG 
5' Wdr83 forward TGATACATTGCAGGGTGGTG 
3' Wdr82 reverse GCCCGTTAGTGAGGGCTTAA 
Ty1 forward GAGGTCCACACCAATCAAGA 
Ty1 reverse GTGGGTCCTGGTTTGTATGC 
  
Recombineering: BAC modification 
 
Ash2l-eGFP forward 
ATCACGTGGAGACAGAAGTGGACGGAAGACGTAGTCCACCCTGGGAACCCGGG 
GAGGTCCACACCAATCAA 
Ash2l-eGFP reverse 
AACATTTGACACTTTATAAAAACAAAAACAAAACCCCCAGGATTATTTTAGGGTCAG 
AAGAACTCGTCAAG 
Bod1l-mVenus forward 
CGAGAGGCCAGCAGAAAGTAGACGAAAACCCTCTGAAAAAGGCAAAGCGGAGC 
AAAGGAGAGGAGCTGTTC 
Bod1l-mVenus reverse 
TCCATTTTCTTTCCACTGGGTTGTTAGTCAGAAAGCTAGAGCCACCATTAGCGTAA 
CAGATGAGGGCAAC 
Cxxc1-eGFP forward 
ACGATCCAACACGATCCACTCACTACCGACCTTCGCTCTAGTGCCGACCGCGG 
GGAGGTCCACACCAATCAA 
Cxxc1-eGFP reverse 
GGCCTCTCCCCTAACTGAATGCAGGGCCGAGAGGCTCTGGGCTGGTGAAGGGG 
TCAGAAGAACTCGTCAAG 
Dppa5a-mVenus forward 
TGAAGCTGGAGGAATCCATGAAGACCCTGGAGCTAGGCCAGTGTATCGAGAGCA 
AAGGAGAGGAGCTGTTC 
Dppa5a-mVenus reverse 
ATGTAACAAAGCTAAAAATCCCGCCAGAACCAAACACTGGCCACAGCTTAGCGTA 
ACAGATGAGGGCAAC 
Men1-eGFP forward 
CACCCAGCGACTACACACTCTCTTTCCTAAAGCGGCAGCGCAAGGGCCTCGGGG 
AGGTCCACACCAATCAA 
Men1-eGFP reverse 
CCTGCTGGGAGTGAGGGCAGGCCTGGGGCCTTGCCACAGAATCAGAGTTCAGG 
GTCAGAAGAACTCGTCAAG 
Ptip-eGFP forward 
CCTTGTGTGTGAAAACCATTTTCCTCAATGAGGCCACATATAAATTTAACGGGGA 
GGTCCACACCAATCAA 
Ptip-eGFP reverse 
CAGCAGCTACCCTTGTGCTCCAGGCTCCAGGCTAGCAGCAGCAAGAGGCCAGG 
GTCAGAAGAACTCGTCAAG 
Wdr82-eGFP forward 
GCTGATTTGTGTTTTCCTTCCAGGCCTTCTGGTTGCCCACCATTGATGACGATAT 
CGAGAACCTGTACTTC 
Wdr82-eGFP reverse 
CTTTTCCTGTTGGCCGCCCTCACTGTATAAATAGCCCAGCAGCATCAGGAGATA 
TCGATGGATGCAGAGTG 
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Recombineering: subcloning 
 
Ash2l-eGFP subcloning forward 
TTCCTATTTCTTCCCTAAAGTACTGAAGTTTATGACACTGCACCTAGCGTCGACGCG
GCCGCGCAGAAGGCCATCCTGACGGA 
Ash2l-eGFP subcloning reverse 
AGTACAAGAATGTAATGCCCCTCTAGTACATAATAAAAAAAAGAATGAATGCGGCCG
CGTCGACTACCGCATCAGGCGCTCTTCC 
Cxxc1-eGFP subcloning forward 
GACAAGATAATCCTGTTACTGCCTATATGTGTCTCATTCATTCCTTCATTGTCGACCC
ATCCTGACGGATGGCCTT 
Cxxc1-eGFP subcloning reverse 
CACTAAAGTTGATTCCAGAAGCTAATCTGTAGGTATTTATGGCCATCCAAGTCGACC
TCTTCCGCTTCCTCGCTCA 
Men1-eGFP subcloning forward 
ACATAAAAAGGCAGACGAAACATCCACACCTAAAAAGAATGCAAGGCTGAGTCGAC
CCATCCTGACGGATGGCCTT 
Men1-eGFP subcloning reverse 
ATTTTCCTTTAGACAGTACTGGAATGTGGAAGACTGGCCACACCCTTTTGGTCGACC
TCTTCCGCTTCCTCGCTCA 
Ptip-eGFP subcloning forward 
TTTTATTGTACTAAAAGGGGAAATTATAGAGAAAATCTTGTGTATTGTATGTCGACCC
ATCCTGACGGATGGCCTT 
Ptip-eGFP subcloning reverse 
GGTTGGTGGCTTCTGAAAACTAGATGTCCTTGTCCTGGGACCATCACTGCGTCGAC
CTCTTCCGCTTCCTCGCTCA 
Wdr82-eGFP subcloning forward 
ATCAAGAGACCCAGAAATGAAAGTGTCATCCACAGGTGACATGGACAAGGGTCGAC
CCATCCTGACGGATGGCCTT 
Wdr82-eGFP subcloning reverse 
CCTGGCTATCCCTTAACTCACTATGTAGACCAGGCTGGCCTCAGACTCAAGTCGAC
CTCTTCCGCTTCCTCGCTCA 
 
3.1.9. PCR products 
  
Product 
 
Fragment size 
(bp) 
  
Chromatin IP  
  
BRCA1 promoter 182 
ENO3 promoter 143 
MAGOHB promoter 205 
Chromosome 9 extragenic region 249 
  
Long Range PCR  
  
5'-Ash2l-Ty1 reverse 5232 
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Ty1 forward-3'-Ash2l 7436 
5'-Cxxc1-Ty1 reverse 5421 
Ty1 forward-3'-Cxxc1 7433 
5'-Men1-Ty1 reverse 5803 
Ty1 forward-3'-Men1 7615 
5'-Ptip-Ty1 reverse 5157 
Ty1 forward-3'-Ptip 7349 
5'-Wdr82-Ty1 reverse 5117 
Ty1 forward-3'-Wdr82 7997 
  
 
Recombineering: BAC modification  
  
Ash2l-eGFP cassette 2527 
Cxxc1-eGFP cassette  2527 
Men1-eGFP cassette 2962 
Ptip-eGFP cassette 2527 
Wdr82-eGFP cassette 3007 
Bod1l-mVenus cassette 1928 
Dppa5a-mVenus cassette 1928 
  
Recombineering: subcloning  
  
pBR322 Ash2l-eGFP 2522 
pBR322 Cxxc1-eGFP   2484 
pBR322 Men1-eGFP  2484 
pBR322 Ptip-eGFP  2484 
pBR322 Wdr82-eGFP  2484 
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3.2. Methods 
 
3.2.1. Obtaining a BAC 
 
A variety of vertebrate genomes, particularly human and murine, are readily 
available as bacterial artificial chromosome (BAC) libraries. The benefit of 
using these BACs as DNA vectors is their high fidelity in sequence 
conservation and optimal size. One BAC can cover 100 – 400 kb genomic 
DNA. With this, most mammalian genes and their regulatory elements can 
be fully encompassed by a single BAC. However, in most cases the cis-
regulatory elements are unknown and not fully annotated. Thus, it remains 
uncertain whether a particular BAC will recapitulate authentic gene 
expression for the chosen gene. Nevertheless, emerging experience 
indicates that this is usually the case. Another uncertainty with BAC 
transgenes involves the presence of additional ORF’s, which may convey 
an unwanted phenotype. Therefore, available BACs should be compared 
and analysed within suitable genomic web browsers, like Ensembl 
(http://www.ensembl.org/index.html).  
The Ensembl browser also allows detailed sourcing, comparison and 
analysis of genomic data, transcripts and proteins, as well as known gene 
regulatory domains (eg. CpG islands, histone methylation sites) or DNA 
polymorphisms. Using the browser, genes or genomic sites of interest can 
be found by searching either by the gene name or sequence blast. If 
possible select genes from “Havana” or “Vega” (manually annotated 
genome) which is more reliable annotated than the default “Ensembl” 
annotation.  
Selected genes are optimally displayed in the “Location-based display” or 
“Gene-based display” mode, with genomic annotations of the gene and 
transcripts. To search for BACs covering this region, the Ensemble browser 
needs to be configured via the menu tab “Configure this page”. In the newly 
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opened “Control Page” window, various BAC libraries (CHORI-29 clones 
and M37-129AB22) are selectable as “External Data”. After saving the 
settings, the browser renews and will display BACs covering the specific 
genomic location. By clicking on the individual BAC maps, information about 
the genomic region covered (Start and Stop positions on the chromosome), 
source and Identification number (Id) of the specific BAC can be found. 
Selected BACs can then be obtained from the specific genome provider 
(e.g. C57BL/6J BAC from Childrens Hospital Oakland Research Institute 
(CHORI), http://bacpac.chori.org; bMQ BAC from Geneservice, 
http://www.geneservice.co.uk/home/).   
The genomic DNA sequence covered by the selected BACs was exported 
in a suitable format, possible by the “Export data” menu tab of the 
Ensemble browser, into a DNA management program like VectorNTI 
(Invitrogen) or Gene Constructor Kit (TEXTCO BioSoftware) for in silico 
design of the final tagged BAC transgene. The BAC sequence, covering the 
genomic DNA and BAC backbone (normally pBACe3.6), is essential for the 
design of the recombineering strategy (e.g. generation of constructs, 
oligonucleotides needed for recombineering and sequencing), as well as for 
the analysis to generate restriction maps for analytical BAC digestion.  
 
3.2.2. Design of the tagging cassette 
 
Four types of C-terminal tagging cassettes generated by Jun Fu (2Ty1-
SBP-PreS-eGFP-IRES-neo, 2Ty1-2PreS-eGFP-PGK/ -actin-em7-neo, and 
mVenus-T2A-gb3-neo) and a plasmid driving the expression of the Red/ET 
system (pSC101-BAD-Red A) were used in this work (Fig. 7). 
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Fig. 7. Plasmids used for BAC tagging. (A) All recombineering steps require the plasmid pSC101-
BAD-Red A (or pSC101-BAD-Red ) for the L-arabinose inducible expression of the l-Phage 
proteins . This plasmid conveys tetracycline resistance. (B-E) Different and multipurpose tagging 
cassettes. These plasmids serve as templates for PCR amplification using oligonucleotides that also 
contain the 50 nt homology arms. These plasmids were replicated in the special host, GB05-pir.  
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The tagging cassette template plasmids are based on the R6K-origin, which 
requires the Pi protein for their replication (Filutowicz et al., 1986). Most 
standard E.coli hosts lack Pi so R6K plasmids will not replicate. 
Consequently, a) antibiotic resistant colonies caused by carryover of the 
PCR template (rather than the intended recombineering event) are 
completely eliminated; and b) this R6K plasmid needs to be grown in a 
special Pi+ host such as GB05-pir.  
Depending on the version, the C-terminal tagging cassette can be 
composed by the elements listed below:  
• 2xTy1, two copies of the Ty1 peptide. 
• SBP, 33 a.a. streptavidin binding protein (Keefe et al., 2001) 
• PreS, two copies of the recognition sequence for PreScission protease (GE 
Healthcare) enabling the specific elution of the purified protein from affinity-
tag columns (Walker et al., 1994);  
• eGFP, the coding region for the enhanced Green Flourescent Protein or 
mVenus, the coding region for codon optimized, CpG dinucleotide-reduced, 
Venus fluorescence protein (Nagai et al., 2002).  
• loxP, target site for the deletion of the PGK-neo or -actin gene upon Cre 
recombination; 
• FRT, target site for the deletion of the T2A-neo upon Flp (Flpe/FlpO) 
recombination (Raymond and Soriano, 2007); 
• An internal ribosome entry site (IRES); 
• PGK (the human phosphoglycerate kinase) or -actin promoter; 
• em7, the E.Coli em7 promoter, which is embedded in the 5’ non-coding 
region of the neo gene; 
• gb3, the E.Coli gb3 promoter, which is included within the open reading 
frame of the neomycin/kanamycin antibiotic resistance coding region; 
• neo, the coding region for neomycin/kanamycin resistance gene; 
• polyA, the SV40 polyadenylation region; 
The antibiotic resistance gene in the tagging cassette was configured to 
express in E.Coli as well as in mammalian cells (Angrand et al., 1999). In 
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E.Coli, the gb3 or em7 promoter drives expression. In mammalian cells, 
expression is driven by an independent eukaryotic promoter (PGK or -
actin) or polycistronically by a T2A peptide (Szymczak and Vignali, 2005) or 
an IRES sequence (Hellen and Wimmer, 1995). For the T2A or IRES 
polycistronic strategy, expression of antibiotic resistance is directly 
dependent on the expression of the tagged gene. Thus, if the tagged gene 
is not expressed in the host cells during selection, the -actin/PGK versions 
must be used. The PGK or -actin promoter/antibiotic resistance gene are 
flanked by the loxP target sites for Cre-recombinase, so that this region can 
be removed in a subsequent site specific recombination step, since the 
presence of strong promoter/antibiotic resistance gene might interfere with 
the expression of the tagged gene, either at the transcriptional level by 
promoter interference or at the post-transcriptional level by impaired RNA 
processing.  
 
3.2.3. Preparation of the tagging cassette by PCR  
 
The final BAC transgene was first made in silico, using a DNA management 
program so that the sequence of the tagging cassette was inserted in frame 
at the stop codon, replacing the endogenous stop of the chosen gene. The 
homology arms to be included in the PCR oligonucleotides are the 50 nt 
upstream, and the reverse complement of the 50 nt downstream, of the stop 
codon.  
71mer PCR oligonucleotides were designed for each gene to attach the 
homology arms. The 5’ oligonucleotide consists of 50 nt upstream of the 
stop codon followed by 21 nt of the 5’ PCR primer.  Thereby the sequence 
of the protein tag is fused in-frame onto the coding region of the chosen 
gene. The 3’ oligonucleotide consists of the reverse complement sequence 
of the first 50 nt downstream of the stop codon, followed by 21 nt of the 3’ 
PCR primer. The stop codon is not included in either homology arm. High 
fidelity proof reading polymerase, like Phusion or Phusion Flash was used 
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for the PCR following the manufacturer’s instructions.  
The PCR product was concentrated and purified using a standard PCR 
purification kit (MSB Spin PCRapace).  
The PCR product was eluted with 20 l ddH2O. 
 
3.2.4. Transformation with Red/ET expression plasmid 
 
Tagging BAC by recombineering requires multiple steps. A resistance to a 
specific antibiotic characterizes each step. Selecting for one or the other 
facilitates the process of recombineering. Usually, the BAC carries 
chloramphenicol resistance; The Red/ET expression plasmid conveys 
tetracycline resistance. On the other hand the tagging cassette conveys 
kanamycin resistance, so that the subsequent acquisition of kanamycin 
resistance indicates the insertion of the cassettes into the BAC by 
homologous recombination.  
For recombineering, the first step involves the introduction of an inducible 
Red/ET expression plasmid into the E.coli host harboring the chosen BAC. 
The Red/ET expression plasmid encodes the three genes from the  phage 
Red operon, Redg (an inhibitor of RecBCD), Red  (a DNA annealing 
protein) and Reda. 
BACs are usually shipped by the genome suppliers inside an E.coli host 
strain.  
 
Cells were streaked out the glycerol stock of the E. coli BAC on LB agar 
plates with 15 μg/ml chloramphenicol and incubated at 37°C overnight with 
shaking. 
From 6 to 10 colonies of E. coli carrying the BAC were picked from the plate 
and inoculated into microfuge tubes containing 1.0 ml LB medium plus 15 
μg/ml chloramphenicol. The tubes were incubate at 37°C overnight with 
shaking (Eppendorf Thermomixer). 
The next day, two microfuge tubes containing fresh 1.4 ml LB medium with 
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15 μg/ml chloramphenicol were set up and inoculated with 30 μl of fresh 
overnight culture. The cells were cultured for 2-3 h at 37°C by shaking at 
1000 rpm. The cells were centrifuged for 30 s at 9.000 rpm in a cold 
benchtop centrifuge, the supernatant was discarded and the cell pellet was 
placed on ice. The cell pellet was resuspended in 1 ml ice cold ddH2O, 
pipetted up and down three times to mix the suspension. This wash step 
was repeated one more time and the cells were resuspended in 20-30 μl of 
ice cold 10% glycerol. 1 μl (about 10-100 ng) pSC101-BAD-Red  or 
water as a negative control was added to the cell pellets. The cell 
suspensions were transferred from the tubes to the chilled electroporation 
cuvettes. The cells were electroporated in the 1 mm gap electroporation 
cuvette at 1350 V, 10 F, 600 Ohms = ~ 5ms pulse time (Electroporator 
2510, Eppendorf). The cells were diluted by adding 1 ml LB medium without 
antibiotics to the cuvettes and transferred to the microfuge tubes. The cells 
were incubated at 30°C for 70 min, shaking at 1000 rpm for recovery. The 
Red/ET expression plasmid pSC101Redabg is replicated at 30°C but not at 
37°C, because replication of the pSC101 plasmid is temperature sensitive. 
100 μl cells were plated on LB agar plates containing the antibiotics to 
select for the BAC and the Red expression plasmid (i.e. 15 μg/ml 
chloramphenicol plus 3 μg/ml tetracycline). The plates were incubated at 
30°C overnight. 
 
3.2.5. Inserting the tagging cassette into a BAC 
 
5-10 colonies from the tetracycline and chloramphenicol plate were 
inoculated in one microfuge tube containing 1.0 ml LB medium plus 
antibiotics and incubated while shaking at 30°C overnight. The next day, 
two microfuge tubes (for sample and negative control) containing fresh 1.4 
ml LB medium with 15 μg/ml chloramphenicol plus 3 μg/ml tetracycline  
were inoculated with 40 μl from the overnight culture. The cells were 
cultured for about 2 h at 30°C, shaking at 1100 rpm until OD600nm = 0.3. To 
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enable recombineering, expression of the Red-proteins from pSC101-BAD-
Redabg transformed in E. coli host containing the BAC was induced by the 
addition of 20 μl of 10% L-arabinose to the sample but not to the negative 
control. The cells were incubated at 37°C shaking for 45 min to 1 h. The 
cells were centrifuged for 30 sec at 9.000 rpm in the cold benchtop 
centrifuge, the supernatant was discarded and the cell pellet was placed on 
ice. The cell pellet was resuspended in 1 ml ice cold ddH2O, pipetted up 
and down three times to mix the suspension. This wash step was repeated 
one more time and the cells were resuspended in 20-30 μl of ice cold 10% 
glycerol.  
The purified tagging cassette (100-200 ng of DNA) was electroporated in 
both induced and uninduced (negative control) cells. Cells were 
electroporated in the 1 mm gap electroporation cuvette at 1350 V, 10 F, 
600 Ohms = ~ 5ms pulse time (Electroporator 2510, Eppendorf). Cells were 
diluted by adding 1 ml LB medium without antibiotics to the cuvettes and 
transferred to the microfuge tubes, to be then incubated at 37°C with 
shaking for 60-90 min for recovery. After recovery, 100 l of cells were 
streaked onto LB agar plates (pH 8.0) containing 15 μg/ml chloramphenicol 
(to select for the BAC) and 15 g/ml kanaymcin (to select for the integration 
of the tagging cassette). The plates were incubated at 37°C overnight.  
 
3.2.6. Quality control of recombineering  
 
To check for successful recombineering of the tagged BAC transgene, two 
tests were performed. First, the BAC transgene was examined using 
restriction enzymes. To isolate the BAC DNA, 5 or more colonies were 
picked for BAC mini-preps and compared to the original unmodified BAC.  
Second, the 5’ recombineering junction was sequenced either after PCR 
amplification or directly using BAC mini-prep as template. Sequencing 
across the 5’ homology arm and PCR primer region into the 5’ end of the 
tagging cassette ensures that the reading frame is intact and excludes the 
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possibility that the 5’ synthetic oligonucleotide has introduced an unwanted 
mutation.  
 
3.2.7. BAC/plasmid Mini-prep protocol and restriction 
analysis of DNA 
 
Single colonies were picked and cultured in 1.6 ml LB plus 15 g/ml 
chloramphenicol and 15 g/ml kanamycin. The cells were incubated in a 
ThermoMixer at 37°C, 1000 rpm for 14-16 hours. From each culture 200 l 
were transferred into fresh microfuge tubes. These aliquots serve as 
backup cultures of the individual clones. The remaining over night cultures 
were spun down at 11000 rpm for 1 min and the supernatant was 
discarded. The cells were resuspended in 200 μl of buffer P1 (50mM Tris-
HCl, pH 8.0, 10mM EDTA, pH 8.0, 100 g/ml Rnase A) and mixed 
thoroughly by vortexing. Then, the cells were lysed by adding 200 μl of 
buffer P2 (200 mM NaOH, 1% SDS) and mixed by inverting the sealed tube 
4 to 6 times. Lysis was completed by incubating at room temperature for not 
more than 5 min. The cells were finally neutralized with 200 μl of buffer P3 
(3.0 M potassium acetate, pH 5.5) by immediately inverting the sealed tube 
4 to 6 times. The tubes were placed on ice for 10 min. The white lysate was 
spun down in a centrifuge at highest speed for 10-20 min at 4°C. The clear 
supernatant was transferred into the new tubes containing 500 μl of 100% 
isopropanol. The samples were centrifuged at highest speed for 20 min at 
4°C to precipitate DNA. The supernatant was discarded and the DNA pellet 
was gently washed with 1 ml of 70% ethanol. The supernatant was carefully 
aspirated and the DNA pellet was dried at 45 °C in a ThermoMixer for 10-20 
min. The DNA pellet was dissolved in 20 l of H2O or directly in digestion 
buffer for the chosen restriction enzyme. After restriction digestion, the 
samples were resolved on a 0.7% agarose gel at 60 Volts or less. 
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3.2.8. BAC Maxi-prep Protocol  
 
BAC DNA maxi preparations were made by using NucleoBond BAC 100 
following the manufacturer’s instructions.  
 
3.2.9. Generation of gene targeting constructs by 
recombineering 
 
During this recombineering step the tagging cassette plus regions of 4 to 5 
kb either side will be subcloned from the tagged BAC into a PCR amplified 
pBR322 backbone to create a plasmid subclone (Fig. 8).  
 
 
Fig. 8. Subcloning the gene targeting construct from the BAC transgene. The subcloning vector 
is PCR amplified using oligonucleotides containing the homology arms at their 5’ end and PCR 
primers at their 3’ ends. Note the orientation of the homology arms with respect to the PCR primers.  
The PCR product is electroporated into an E coli host harbouring the target BAC (illustrated) 
containing the region to subclone and recombineering expression plasmid, pSC101-BAD-Red . 
Selection for ampicillin resistance (from the linear vector) plus kanamycin resistance (from the 
tagging cassette) selects for recombinants.  
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The ends of the 4 to 5 kb regions are defined by 50 nt HAs, which are 
selected by ordering ~75 nt oligonucleotides (including 25 nt for PCR 
primers at their 3’ ends) and attached to the pBR322-ori-ampicillin vector by 
PCR. Technically, this is very similar to the tagging recombineering step 
described above. However, conceptually it is different because the tagging 
step is based on insertion of a PCR product into a BAC whereas subcloning 
is based on subcloning a defined region from the BAC into a plasmid. This 
subcloning mechanism has also been called ‘gap repair’ because the 
pBR322-ori-ampicillin PCR product must circularize before it can replicate. 
In practice, the key difference between inserting a cassette and subcloning 
is the orientation of the homology arms.  
The two oligos for subcloning are used as linkers between the genomic 
DNA fragment to clone from a BAC and the pBR322-origin-amp backbone.   
The design of the oligos was done by generating the construct first in silico 
using DNA management software.  
The 5’ prime 50 nt homology arm (HA) was designed to start around 4 to 5 
kb upstream from the tagging cassette, plus 25 nt PCR primer to the 
pBR322 plasmid template. The 3’ oligonucleotide was similarly composed 
and directed to the other end of the pBR322 acceptor plasmid, plus the 3’ 
HA, located around 4 to 5 kb downstream from the tagging cassette (Figure 
3).  
The vector cassette was prepared by a high fidelity PCR. 
 
3.2.10. Subcloning of a specific region from a BAC by 
Red/ET  
 
The E. coli strain carrying the BAC was transformed with the pRed/ET 
expression plasmid as above described in the section “Transformation with 
Red/ET expression plasmid”. Colonies of the E. coli strain carrying the BAC 
and pSC101-BAD-Red  were picked from the plate and inoculated in a 2 
ml microfuge tube containing 1.0 ml LB medium plus tetracycline (3 g/ml), 
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chloramphenicol (15 g/ml) and kanamycin (15 g/ml). The cultures were 
incubated while shaking at 30°C overnight.  Two microfuge tubes were set 
up a) for the subcloning, b) as uninduced control. 30 l fresh overnight 
culture were inoculated in 1.4 ml LB medium conditioned with antibiotics. 
The tubes were incubated at 30°C for approximately 2 h, shaking at 1100 
rpm until OD600nm ~ 0.3. Then 10% L-arabinose was added to tube (a), 
giving a final concentration of 0.1%-0.2%. The other tube was left without L-
arabinose induction as non-induced negative control. The two tubes were 
incubated now at 37°C, shaking for 45 min to 1 h.  
The cells were centrifuged for 30 sec at 9.000 rpm in a cold benchtop 
centrifuge and the supernatant discarded. The cell pellet was resuspended 
with 1 ml ice cold ddH2O, pipetting up and down three times to mix the 
suspension. This wash step was repeated one more time and the cells were 
resuspended in 20-30 μl of ice cold 10% glycerol.  
The purified linear vector PCR product was added to the cell pellet (100-200 
ng DNA). DNA was electroporated in both induced and uninduced (negative 
control) cells. The cells were electroporated in the 1 mm gap electroporation 
cuvette at 1350 V, 10 F, 600 Ohms = ~ 5ms pulse time (Electroporator 
2510, Eppendorf). The cells were diluted by adding 1 ml LB medium without 
antibiotics to the cuvettes and transferred to the microfuge tubes, to be then 
incubated at 37°C with shaking for 60-90 min for recovery. 100 l of cells 
were streaked onto LB agar plates (pH 8.0) containing ampicillin (100 
g/ml) and kanamycin (15 g/ml). The plates were incubated at 37°C 
overnight.  
 
3.2.11. Verification and preparation of DNA for targeting  
 
At least 2-4 ampicillin and kanamycin resistant colonies were picked from 
the plate. Plasmid DNA was extracted using a standard plasmid DNA 
preparation protocol as described on the section "BAC/plasmid Mini-prep 
protocol and restriction analysis of DNA". Then the DNA was analyzed by 
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restriction digestion and agarose gel electrophoresis. 
40 g of plasmid DNA were linearized by suitable restriction enzymes, 
which cleave at the junction between the tagging cassette and the plasmid 
backbone. The linearized fragments were purified by phenol/chloroform 
extraction and the DNA was precipitated by ethanol and resuspended in 30 
l PBS.  
 
3.2.12. Culture conditions for mouse embryonic stem cells  
 
Feeder-independent E14tg2a mouse embryonic stem cells were cultured 
according to standard protocols, using appropriate mouse ES medium 
(Dulbecco’s Modified Eagles Medium, DMEM with 4.5 g/l glucose; 15% 
Fetal Calf Serum; 2 mM L-glutamine; 0.1 mM MEM non-essential 
aminoacids; 1 mM sodium pyruvate; 0.1 mM -mercaptoethanol, 1000 U/ml 
Leukemia Inhibitory Factor; 100 U/ml, streptomycin, 100 U/ml penicillin). 
Cells were passaged every second day using 0.25% trypsin-EDTA.  
 
3.2.13. Transfection of mouse ES cells to establish stable 
BAC transgenic lines 
 
ES cells were seeded 1 day before transfection with a density of 2.5 x 105 
cells/well of 6-well plates in 2 ml mouse ES medium. The next day the 
medium was changed before transfection to keep cells proliferating. 
Transfection was carried out using Lipofectamine LTX PLUS system 
(Invitrogen) and performed using the supplier’s protocol. In brief, 1 μg of 
BAC DNA was diluted in 500 μl OPTI-MEM and well mixed. The diluted 
DNA was mixed with 2.5 μl of PLUS reagent and incubated for 5 min at 
room temperature. Then 6.25 μl of the Lipofectamine LTX solution were 
gently mixed with the DNA and the mixture was incubated for at least 20 
min at room temperature. The cells were transfected by distributing the 
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entire DNA-lipid mixture dropwise to the 2 ml mouse ES medium of one 
well. For stable transfection, the cells were subjected to 100-200 g/ml 
G418 selection in mouse ES medium 24 h after lipofection.  The medium 
was changed every day. After 6-12 days resistant ES cell colonies were 
picked. To test for expression of the tagged protein, several ES cell clones 
were evaluated. Because the number of integrated BACs can vary, 
expression can differ between individual clones.  
 
3.2.14. Electroporation of mouse ES cells 
 
ES cells were seeded 1 day before electroporation at a density of 1-2x106 
cells in 10 cm dishes in mouse ES medium (Dulbecco’s Modified Eagles 
Medium, DMEM with 4.5 g/l glucose; 15% Fetal Calf Serum; 2 mM L-
glutamine; 0.1 mM MEM non-essential aminoacids; 1 mM sodium pyruvate; 
0.1 mM -mercaptoethanol, 1000 U/ml Leukemia Inhibitory Factor; 100 
U/ml, streptomycin, 100 U/ml penicillin). 
On the next day the cells were washed once in PBS and harvested by 
incubation in 1 ml of 0.05% Trypsin/EDTA for 3 min at 37°C. In order to get 
a single cell suspension 10 ml of mouse ES medium were used to mix.  
The cell suspension was spun down at 800 g and the cell pellet was 
resuspended in 900 μl PBS. The electroporation was carried out with a 
Gene Pulser (BioRad) using the exponential settings (4 mm Distance, 
250V, 500μF) adding 20-40 μg linearized targeting construct to 5x106 cells. 
After electroporation the cells were quickly plated in five fresh 10 cm dishes 
with 10 ml mouse ES medium. The next day fresh mouse ES medium 
containing 100-200 μg/ml G418 was added. Resistant ES cell colonies were 
detected and picked after 6-12 days. 
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3.2.15. Picking Colonies for clonal analysis 
 
G418 resistant colonies were picked 6-12 days after transfection or 
electroporation of the ES cells. The mouse ES cell medium was replaced 
with 2ml PBS. An inverted phase contrast/fluorescence microscope was 
used at 2.5 to 5x magnification for better visualization of the colonies to 
pick. Single colonies were scraped from the plastic with a sterile 20 l 
pipette tip. The loose colony was aspirated into the tip. Each colony was 
placed into a separate well of a 96 well dish. The cells of a colony were 
separated by adding 25 μl of 0.25% trypsin-EDTA to each well. The 96 well 
was than incubated for 5 min at 37°C. 125 μl of mouse ES medium were 
added to each well and the mixture was pipetted to resuspend the cells as a 
single cell suspension. The medium was daily replaced. After 2 days, the 
clones were transferred and expanded in wells/dishes of increasing size 
according to the growth of each clone.  
 
3.2.16. Genomic DNA extraction from 96 well 
 
ES cell targeted clones were allowed to grow in the presence of selective 
media for 2-3 days. The cell clusters were dissociated with trypsin, and the 
cell suspension was divided into halves. One half was frozen in the plates 
and stored at -80 °C, and the other was plated on gelatin-coated 96-well 
replica plates. The latter cells were allowed to grow to confluence (3-5  
days) and were used as the initial material for the DNA extraction 
procedure. 
The cell lysis was carried out as follows: the cells were washed twice with 
PBS, and 50 μl of lysis buffer was added per well. The lysis buffer was 10 
mM Tris, pH 7.5; 10 mM EDTA, pH 8.0; 10 mM NaCl; 0.5% sarkosyl and 1 
mg/ml proteinase K (added fresh). The plates were incubated overnight at 
55°C in a humid atmosphere to avoid evaporation. The next day, a mix of 
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NaCl and cold ethanol (200 mM NaCl in 100 μl of absolute ethanol) was 
added (150 μl/well). The plates were allowed to stand on the bench for 15-
30 min, until the precipitated nucleic acids could be seen clearly under a low 
power microscope. The supernatant was discarded by inversion of the 
plates, and these were washed with 70% ethanol three times, each time 
discarding the alcohol by inversion. After the final wash, the plates were left 
tilted to air dry for 15-20 min. DNA was finally resuspended in 50 μl of 
ddH2O.  
 
3.2.17. Long Range PCR analysis of targeted clones 
 
The successful targeting of the genomic location is usually confirmed by 
Southern blot analysis. However long range PCR (LR-PCR) offers a fast 
alternative (Fig. 9). 
In the case that the tagged protein is expressed in the tagged cells, the 
combination of LR-PCR and Western blotting can obviate the need for 
Southern analysis.  
Two 20-25 nt primer pairs, one primer pair for the amplification of the 5‘ 
region and another for the 3’ region were used. The 5’ distal primer was 
taken from the genomic DNA sequence a little upstream of the 5’ end of the 
5’ homology arm. Similarly the 3’ distal primer pair was taken from the 
genomic DNA sequence a little further 3’ than the end of the 3’ homology 
arm. The two internal primers anneal to sequences at the 5’ and 3’ ends of 
the tagging cassette and need to be chosen to match the properties of the 
external, genomic primer partner. 
The LR-PCR was performed by using the LongAmp kit (NEB) according to 
the NEB instructions.  
 
In brief, in a 50 l reaction 50 – 500 ng of genomic DNA (purified by phenol-
chloroform extraction and EtOH precipitation) from targeted cells or DNA 
from non-targeted ES cells as a control, 10 μM primers, 10 mM dNTPs and 
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3% DMSO were used.  
The LR-PCR cycling was initiated with a denaturation for 2 min at 94°C. 
The first five cycles were started with 15 s at 94°C, annealing for 15 s at 
65°C and elongation for 7 min at 65°C, by stepwise decreasing the 
elongation temperature by 1°C after each cycle to 61°C. The next 30 cycles 
were then 15 s at 94°C, annealing for 15 s at 65°C and elongation for 7 min 
at 65°C. The last cycle was followed by a final elongation cycle for 10 min at 
65°C.  
 
 
Figure 9. Long Range (LR)-PCR. Depicted are the primer positions to screen by LR-PCR for 
successful targeting. In black are primers with homology to the genomic DNA outside of the 
homology arms (HA). In orange or red are the reverse complement primers with homology to the 
tagging cassette. The integration is analysed by three independent LR-PCR reactions A) amplifying 
the region of the 5’ HA, B) amplifying the region of the 3’ HA, C) control LR-PCR to also detect 
negative clones lacking the tagging cassette.  
 
3.2.18. Preparation of cells for Western blot analysis 
 
For Western blot analysis 1x105- 106 cells were scraped off the culture dish 
in ice-cold PBS and collected by centrifugation at 800 g for 5 min at 4°C. 
The cell pellets were then resuspended in 70 to 100 μl of ice-cold 
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Homogenization buffer (20 mM HEPES pH 8.0; 150 mM NaCl; 1.5 mM 
MgCl2; 10% glycerol; 2 mM EDTA pH 8.0; 0,5% Tween-20) with 1 mM DTT 
and 1x protease inhibitor cocktail added immediately prior to use. Cell 
extracts were briefly sonicated in the BioRaptor waterbath sonicator 
(Diagenode) to shear the chromatin.  
After cell homogenization by sonication, insoluble material was precipitated 
by centrifugation at 14.000 g for 10 min at 4°C. The cleared supernatants 
were transferred into fresh reaction tubes. To achieve equal protein loading 
(20 μg to 100 μg) of multiple samples in the SDS-PAGE, protein 
concentrations of the supernatants were measured at 280nm before mixing 
with 2xSDS sample buffer (Sigma) and denaturation at 95°C for 5 min. 
Finally, the samples were directly loaded and resolved on 8-10% 
polyacrylamide gels and transferred to Immobilon-P PVDF membranes 
(Millipore) by semidry blotting. Blotting was performed for 1 h at 15 V. 
Membranes were incubated in blocking solution (1% BSA, 0.05% Tween20 
in PBS) with 1:5000 dilution of purified goat polyclonal anti-GFP antibody 
(MPI-CBG Dresden) overnight at 4°C. After extensive washing (three times 
wash with 0.05% Tween20 in PBS), membranes were incubated with an 
anti-goat horseradish-peroxidase conjugated secondary antibody (diluted 
1:10.000) for 1 h at RT. Prior to detection, membranes were washed as 
described above and the bound antibody was visualized with Supersignal 
West Pico substrate kit by Luminescent Image Analyzer LAS-3000 (Fujifilm 
Life Science).  
 
3.2.19. Fluorescence analysis of the GFP expressing cell 
lines 
 
Undifferentiated mouse ES cells were plated on gelatin-coated glass 
coverslips. The cells were fixed with 4% formaldehyde in PBS for 10 min at 
RT. Cells were washed twice with PBS and the nuclei counterstained with 
0.1 μg/ml DAPI. Coverslips were finally mounted with Mowiol-DABCO and 
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imaged with a Leica SP5 upright laser scanning confocal microscope. 
 
3.2.20. Small scale immunoprecipitation of GFP/Venus-
tagged proteins  
 
Before starting protein A/G agarose beads were prepared for the 
immunoprecipitation. Briefly, the protein A/G-agarose beads were pelletted 
by centrifugation at 1000 g for 1 min. Beads were washed two times more 
and then resuspended in Homogenization buffer. 
Cells expressing GFP/Venus fusion proteins and control cells were cultured 
to yield 107. After rinsing with PBS, cells were scraped in ice-cold PBS and 
collected by centrifugation at 800 g for 5 minutes at 4°C. The cell pellet was 
resuspended in 200 l ice-cold Homogenization buffer (20 mM HEPES pH 
8.0; 150 mM NaCl; 1.5 mM MgCl2; 10% glycerol; 2 mM EDTA pH 8.0; 0,5% 
Tween-20) with 1 mM DTT and 1x protease inhibitor cocktail, and 
transferred to a 1.5 ml microfuge tube. Cells were homogenized either by 
sonication in a waterbath sonicator (BioRaptor, Diagenode): 10 min, high 
power, alternating between 15 - 30 s ON and 30 s OFF) in the cold room 
placing the tube on icewater when not sonicating. After homogenization 
samples were cleared by centrifugation at 12.000 g for 10 min at 4°C. The 
cleared supernatants were transferred into new microfuge tubes and 
immediately processed or stored at -80°C. 
For the immunoprecipitation (IP), the cleared supernatants were diluted to a 
volume of 500 l and incubated with 20 l of bead slurry plus 5-6 g of goat 
anti-GFP antibody. The IP was performed for 1-3 h at 4°C by gently mixing. 
After incubation, the beads were centrifuged at 100 – 500 g and 
subsequently washed 2 times with 1 ml Homogenization buffer for 5 min. 
After the last washing step, bound proteins were eluted by resuspending the 
beads in 1xSDS sample buffer followed by denaturation at 95°C for 5 min.  
Protein samples were loaded on a polyacrylamide gel for Western Blot 
analysis. 
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3.2.21. Immunoprecipitation of GFP-tagged proteins for 
mass spectrometry 
 
Big scale protein immunoprecipitations for mass spectrometry were 
performed by Dr. Nina Hubner (Prof. Matthias Mann's research group, Max 
Planck Institute of Biochemistry, Martinsried, Germany) using a label-free 
approach as described in Hubner et al., 2010.  
In label-free experiments, tagged and control cells are cultured in normal 
media, and separate pull downs are performed. Eluates are not mixed but 
analyzed separately by LC-MS/MS. Proteins are quantified with the label-
free algorithm in Max-Quant software (Fig. 10).  
True interaction partners could be distinguished from background binders 
present in the immunoprecipitations by their quantitative ratios.  
The statistical significance to pull down results was assigned using a t test 
comparing the three IPs with the three controls. Proteins based on a 
combination of this p-value and the observed fold changes were accepted. 
The software package QUBICvalidator calculates a significance curve 
separating binders from background in the fold change versus p-value 
plane. The logarithmic ratios of protein intensities are plotted against 
negative logarithmic p-values of the t test performed from triplicates. The 
hyperbolic curve separates specifically interacting proteins from 
background. 
The higher is the value the more "significant" the result is, in the sense of 
statistical significance. 
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Fig. 10. Label free approach for Mass Spectrometry. Samples and controls are separately 
immunoprecipitated with an anti-GFP antibody and subjected to HPLC MS/MS. Significance of 
samples over controls are calculated by the MaxQuant software. 
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3.2.22. Chromatin Immunoprecipitation protocol for deep 
sequencing analysis 
 
The basis of ChIP is the immunoprecipitation step, in which an antibody is 
used to enrich chromatin. In ChIP–seq, next-generation technology is used 
to deep sequence the immunoprecipitated DNA molecules and thereby 
produce digital maps of ChIP enrichment (Fig. 11). 
 
 
Fig. 11. Flowchart of Chromatin immunoprecipitation assay. Cells are crosslinked with 
formaldehyde and lysed. Cell extracts are sonicated to shear chromatin in a fragment range between 
200-500 bp. Immunoprecipitation is performed with a specific antibody and DNA is later purified for 
downstream applications. 
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Approximately 108 cells expressing the tagged protein were cultured. For a 
ChIP control, the original non-transfected cells (eGFP negative) were used. 
Cells were crosslinked by adding formaldehyde dropwise directly in culture 
medium while gently mixing to a final concentration of 1% and incubated for 
10 min at RT. Formaldehyde reaction was quenched by adding glycine to 
125 mM and incubating for 5 min at room temperature. 
The medium was aspirated and the cells were washed with ice-cold PBS. 
The cells were harvested using a rubber scraper and collected by 
centrifugation for 4 min at 1500 rpm at 4˚C. The supernatant was removed 
and the cell pellet was resuspendeded in 1ml ChIP buffer (0.01% SDS; 
1.1% Triton X- 100; 1.2 mM EDTA, pH 8.0; 16.7 mM Tris-HCl, pH 8.1; 167 
mM NaCl; protease inhibitor cocktail) and transferred into a fresh 15 ml 
conical tube or other tubes recommended for the sonicator. Sonication was 
performed with a water bath sonicator (BioRaptor, Diagenode) using high 
power for 12 minutes, with 15 s ON then 30 s OFF intervals. The samples 
were centrifuged at 12,000 g for 5 min to precipitate remaining cell debris, 
then the cleared supernatant was transferred into fresh tubes. To check the 
DNA size of the sonicated chromatin, 50 l aliquots were collected and 
treated with 8 l of 5 M NaCl (200 mM final) to reverse the crosslink by 
incubation at 98˚C for 15 min. After cooling down, 2 l of Proteinase K 
solution (10 mg/ml) were added and the chromatin solution was incubated 
at 55˚C for 30-60 min. The size of sonicated DNA was verified by gel 
electrophoresis using a 1.5 - 2% agarose gel.  
For a preclearing step protein A/G-agarose beads were prepared. Shortly, 
100 l protein A/G-agarose per sample in PBS were pelletted by 
centrifugation at 1000 g for 1 min. Beads were washed two times more and 
then resuspended in 1 ml ChIP buffer. 
The supernatants of the sheared samples were transferred into fresh 15 ml 
low DNA binding polystyrene tubes (BD Falcon). The chromatin was pre-
cleared by 100 l protein A/G-agarose beads. Samples were adjusted to 3 
ml with ChIP buffer and incubate for 1 h while gently rotating/mixing at 4˚C 
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to reduce nonspecific protein or DNA binding to the beads. The beads were 
collected by centrifugation at 200 g and the whole supernatant was 
transferred into fresh 15 ml low DNA binding polystyrene tubes (BD Falcon). 
One 50 l aliquot of each sample was placed into a fresh tube and froze 
down at -20°C. This is the total DNA INPUT sample later used for qPCR 
analysis of sample enrichment at known genomic loci.  
For the immunoprecipitation, 40-70 g goat anti-GFP antibody were used. 
Samples were incubated overnight while gently rotating/mixing at 4˚C. On 
the next day, 200 μl protein A/G-agarose beads were washed and prepared 
as previously described. After the last washing step beads were 
resuspended in 1ml PBS containing 200 g sonicated Salmon Sperm DNA 
and 1.5% cold water fish skin gelatin. The mixture was incubated while 
rotating for at least 2 h at 4°C. The beads were finally washed once with 1 
ml ChIP buffer and stored in 0.5 ml ChIP buffer at 4°C. The pre-blocked 
beads were added to the ChIP samples, which were now incubated while 
gently rotating/mixing for 1-2 h at 4˚C. 
The beads were collected by centrifugation at 200 g. The remaining 
supernatant was discarded. The beads were carefully transferred with 1 ml 
ChIP buffer into 1.5 ml LoBind tubes (Eppendorf) and washed by rotating 
for 3-5 min at 4˚C.  
The beads were again pelletted by gentle centrifugation at 200 g. After 
discarding the supernatant, the beads were washed for 5 min at 4˚C in 1 ml 
of each the buffers listed below as described before:  
 
a. Twice with ice-cold Low Salt Immune Complex Wash Buffer (0.1% SDS; 1% 
Triton X-100; 2 mM EDTA pH 8.0; 20 mM Tris-HCl pH 8.0; 150 mM NaCl) 
 
b. Twice with ice-cold High Salt Immune Complex Wash Buffer (0.1% SDS; 
1% Triton X-100; 2 mM EDTA pH 8.0; 20 mM Tris-HCl pH 8.0; 500 mM 
NaCl) 
c.  Twice with ice-cold LiCl Immune Complex Wash Buffer (0.25M LiCl; 1% 
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IGEPAL CA630 (SIGMA); 1% deoxycholic acid (sodium salt); 1 mM EDTA 
pH 8.0; 10 mM Tris pH 8.0) 
 
d. Twice with ice-cold TE buffer (10 mM Tris-HCl pH 8.0; 1 mM EDTA pH 8.0) 
Before spinning down after the last washing step transfer a 50 l aliquot of 
beads suspension from each sample into a fresh tube for analyzing the IP 
pull down by Western blot. 
 
The precipitated protein complexes were eluted by adding 250 l freshly 
prepared elution buffer (1% SDS, 0.1 M NaHCO3) to the pelletted beads. 
Samples were briefly vortexed and incubated at room temperature for 15 
min while rotating. The beads were collected by centrifugation at 200 g and 
the supernatants were transferred into fresh 1.5 ml LoBind tubes 
(Eppendorf). Elution was repeated once again. Both eluates were combined 
resulting in 500 μl total. The input sample was thawed and brought to 500 l 
with elution buffer. To reverse cross-links the eluates and input samples 
were treated with 20 l 5 M NaCl (200 mM final). The protein-DNA 
complexes were released by incubation at 65 ˚C for > 4 h or overnight. To 
digest proteins, the eluates and input samples were treated with 2 l 
proteinase K (10mg/ml solution), 10 l of 0.5 M EDTA pH 8.0 (10 mM final), 
20 l of 1 M Tris-HCl pH 6.5 (40 mM final). Samples were incubated for 1 h 
at 55˚C shaking at 800 rpm in a ThermoMixer.  
After cooling down to room temperature (RT), the DNA was purified with 
500 l phenol/chloroform/isoamyl alcohol (25:24:1) by vortexing and 
spinning down at 12000 g for 2 min at RT. The top aqueous phase was 
transferred into a new 1.5 ml tube and the DNA was collected by EtOH 
precipitation followed by centrifugation at highest speed at 4˚C. The DNA 
pellet was washed with 1 ml 70% ethanol, and the pellet was dried at RT for 
15 – 30 min. The DNA pellets were resuspended in 21 l ddH2O. The 
samples were frozen down at -20˚C. 
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3.2.23. qPCR analysis for the enrichment of the ChIP DNA 
on specific loci 
 
The quality and quantity of DNA specifically pulled down in the ChIP is best 
determined by qPCR. Validated PCR primer pair for a genomic DNA 
sequence that is known to be a target site of the tagged protein is used.  
For the qPCR 1 l of each ChIP sample and input sample was respectively 
diluted 1:10 and 1:500 in ddH2O. 1 l of the diluted DNA was used for a 20 
l PCR reaction. The qPCR was performed with the Brilliant II FAST 
SYBR® QPCR Kit following the instructions of the supplier.  
 
3.2.24. Deep sequencing analysis of the immunoprecipi-
tated DNA 
 
ChIP-seq was performed by Dr. Sergey Denissov (Prof. Henk 
Stunnenberg’s research group, Nijmegen Centre for Molecular Life 
Sciences, Nijmegen, Netherlands) using an Illumina Solexa platform.  
In brief, in the first step of the procedure the ends of the DNA are polished, 
and two unique adapters are ligated to the fragments. Ligated fragments of 
the size range of 150-250 bp are isolated via gel extraction and amplified 
using limited cycles of PCR. Illumina utilizes a unique "bridged" 
amplification reaction that occurs on the surface of a flow cell, which 
provides a large surface area for many thousands of parallel chemical 
reactions. The flow cell surface is coated with single stranded 
oligonucleotides that correspond to the sequences of the adapters ligated 
during the sample preparation stage. Single-stranded, adapter-ligated 
fragments are bound to the surface of the flow cell exposed to reagents for 
polyermase-based extension. Priming occurs as the free/distal end of a 
ligated fragment "bridges" to a complementary oligo on the surface. 
Repeated denaturation and extension results in localized amplification of 
 56 
single molecules in millions of unique locations across the flow cell surface. 
A flow cell containing millions of unique clusters is now loaded into the 
sequencer for automated cycles of extension and imaging. 
The first cycle of sequencing consists first of the incorporation of a single 
fluorescent nucleotide, followed by high resolution imaging of the entire flow 
cell. These images represent the data collected for the first base. Any signal 
above background identifies the physical location of a cluster, and the 
fluorescent emission identifies which of the four bases was incorporated at 
that position. 
This cycle is repeated, one base at a time, generating a series of images 
each representing a single base extension at a specific cluster. Base calls 
are derived with an algorithm that identifies the emission color over time. At 
this time reports of useful Illumina reads range from 26-50 bases. The use 
of physical location to identify unique reads is a critical concept for all next 
generation sequencing systems. The density of the reads and the ability to 
image them without interfering noise is vital to the throughput of a given 
instrument.  
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4. Results 
 
4.1. Generation of C-terminal GFP tagged H3K4 
methyltransferases complex-specific subunits 
 
Histone methyltransferases are essential enzymes that regulate gene 
activation and silencing. Notably, histone H3K4 methyltransferase activity 
appears to be functional exclusively in the context of their multiprotein 
complexes (Table 1). Different studies identified unique proteins in the 
context of each histone H3K4 methyltransferase complex. Potentially, those 
proteins are suitable for a more comprehensive analysis of the complex 
itself, since the actual methyltransferases are difficult to work with because 
of their large molecular weight and sensitivity to protein degradation.  
In order to better understand each complex's function and dynamics, the 
specific subunits Cxxc1 and Wdr82 for Setd1a/b, the unique component 
Men1 for Mll1/2 complexes, and the protein Ptip, found only in Mll3/4 
complexes, were selected for this study. The subunit Ash2l, which is 
common to all the H3K4 methyltransferases, was taken as a reference.  
BACs carrying the genes of interest were obtained from commercial 
sources and modified by recombineering in E.Coli. Each protein was C-
terminal fused with an eGFP-based tag. Different and multipurpose protein 
tags were used during the development of the tagging strategy (Fig. 12). 
Ash2l, Cxxc1 and Ptip carry a tag based on a polycistronic strategy to 
express the neomicyn gene. Men1 and Wdr82 were fused to a tag that 
relies on an indipendent promoter ( -actin or PGK) for the expression of the 
selectable marker. 
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Fig. 12. Modular structure of the tagged complex-specific subunits. 
 
Successful recombination of the BACs was verified by restriction enzyme 
digestion of the BAC DNA. Restriction digest pattern was first predicted in 
silico (Fig. 13 A) with the Gene Construction Kit software (Textco). After 
recombineering, wild type and recombined BACs were digested with the 
appropriate enzymes (Fig. 13 B). Remarkably, all the constructs showed the 
correct restriction pattern according to the prediction. Since the eGFP 
cassettes were PCR-generated, the BACs were subjected to 5' sequencing 
to check point mutations or frameshifts of the coding sequence. Sequencing 
of DNA proved that the high fidelity Phusion polymerase or the 
oligonucleotides did not introduce mutations into the amplified sequence. 
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Fig. 13. Restriction digestion patterns of the BAC constructs. (A) In silico prediction of the 
restriction. (B) BAC DNA digestion with the specific restriction enzymes. SmaI, SacII, HpaI, NheI and 
EcoRV were respectively used to digest Ash2l, Cxxc1, Men1, Ptip and Wdr82. Appearance or 
disapperance of bands in the recombinant rather than control BACs is represented by arrows. 
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4.2. Generation of targeting vectors by subcloning 
 
Genetic modifications in mouse ES cells using homologous recombination 
require the design and construction of targeting vectors to modify specific 
genes. Recombineering simplifies targeting vector construction for the 
modification of mammalian genomes (Angrand et al., 1999).  
The overall experience of Prof. Francis Stewart and Dr. Konstantinos 
Anastassiadis research groups demonstrated that the design of efficient 
targeting constructs is guided by three parameters. Greater adherence to 
these parameters for construction of a targeting vector leads to a greater 
chance of success.  
1. Isogenic DNA is better. Homologous recombination relies on the sequence 
identity between the targeting construct and the genome. The best way to 
secure identity is to use the target genome as the source of the homology 
arms in the targeting construct.  
2. Longer homology arms are better. However in practice, homology arms 
longer than 5 kb create a problem for Southern blot analysis of the targeting 
event. On the other hand, if either arm is shorter than 3 kb, targeting 
efficiency will probably be impaired. 
3. Promoterless selection is better. If the target gene is expressed in the host 
cells, then the targeting construct can be designed so that expression of the 
antibiotic resistance gene is driven by the endogenous promoter after 
homologous recombination. Consequently a greater proportion of resistant 
colonies will be due to correct targeting.  
Targeting constructs for Ash2l, Cxxc1, Men1, Ptip and Wdr82 were 
generated using Red/ET recombineering from the original BAC transgenes 
in a pBR322 backbone plasmid containing an origin of replication and 
ampicillin gene as selectable marker.  
As earlier described, digest predictions were created with the GCK software 
and accordingly the plasmid DNA was screened with an appropriate 
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enzyme (Fig. 14).  At least two clones for each construct showed the correct 
restriction pattern. 
 
 
 
Fig. 14. Restriction digest patterns of the targeting vectors. EcoRI was used to digest Ash2l, 
Men1 and Wdr82 targeting constructs. HindIII and NcoI were respectively used to resolve Cxxc1 and 
Ptip targeting vectors. 
 
 
4.3. Generation of BAC transgenic mouse ES cell lines 
 
Maxi preparations of sequenced BAC constructs were produced with the 
NucleoBond BAC 100 kit. Undifferentiated mouse ES cells were transfected 
by lipofection with 1 μg of BAC DNA in a six well dish format. In order to 
establish stable clones, cells were selected 24-48 h after transfection with 
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G418 for 6-12 days. As a control, cells were transfected without DNA and 
cultured under the same selection conditions.  
At least 6-10 G418 resistant colonies were picked and expanded until the 
10 cm dish format.  No colonies were detected in the mock control.  
The expression of the tagged proteins in the resistant clones was verified by 
Western Blot analysis as described in section 4.5.   
 
4.4. Targeting of mouse ES cells by homologous 
recombination 
 
The targeting vectors were linearized by SalI and purified. Undifferentiated 
mouse ES cells were electroporated with purified DNA and G418 resistant 
colonies were picked and expanded after 6-12 days. 
Correct targeting events were detected by 5' and 3' Long Range PCR (Fig. 
15; here only 5' Long Range PCR is shown) on genomic DNA. 
 
Fig. 15. 5' Long Range PCR screening of targeted clones. Long Range PCR analysis of Ash2l, 
Cxxc1, Men1, Ptip and Wdr82 clones showed correct PCR products, respectively 5232, 5421, 5803, 
5157, 5117 bp. For Cxxc1, Men1 and Ptip the correponding BAC constructs were used as positive 
control (+). 
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Long Range PCR analysis confirmed the successful targeting for all the 
electroporated constructs. A summary of targeting efficiencies is shown in 
Table 2. 
 
 
 
 
 
 
 
 
 
Table 2. Targeting efficiency of the tagged H3K4 HMT subunits in mouse ES cell lines. 
 
 
4.5. Expression of the tagged proteins in mouse ES cell 
lines 
 
Whole cell lysates were prepared from different clones of each BAC 
transgenic cell lines and targeted cell lines. Proteins were resolved by SDS-
PAGE followed by transfer on PVDF membranes, and then later probed 
with an anti-GFP antibody and an anti-Ash2l antibody for Ash2l subclones, 
because an antibody against endogenous Ash2l was commercially 
available. In this later case, tagged and untagged versions of the protein are 
both detectable on the blot, and information on their protein expression level 
can be acquired.  
Ash2l-eGFP (106 KDa) was detected by anti-GFP probing in both BAC 
transgenic and targeted lines selected for the experiment (Fig. 16 A). The 
absence of a signal for the same protein in wild type control confirmed the 
specificity of the GFP antibody. Another Western blot was performed with 
the anti-Ash2l just on one targeted and BAC transgenic clone to compare 
the protein expression level.  
Cell line Targeted clones/total Nr. 
clones 
Targeting efficiency 
(%) 
Ash2l 4/17 23 
Cxxc1 1/100 1 
Men1 4/30 13.3 
Ptip 6/6 100 
Wdr82 22/118 18 
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Interestingly, in the case of the BAC transgenic clone the specific band for 
Ash2l-eGFP was as intense as the endogenous Ash2l band (68 KDa) and 
missing in the negative control (Fig. 16 B). However, Ash2l antibody 
showed a certain unspecificity, detecting a protein at  80 KDa, also present 
in the wild type control. 
 
Fig. 16. Western blot analysis of Ash2l-eGFP clones. (A) Expression of the fusion proteins was 
revealed with the GFP antibody. (B) Protein expression level was detected with anti-Ash2l. Ash2l 
GFP fusion protein is indicated by a red arrow. Endogenous Ash2l protein is represented by a blue 
arrow. 
 
This result demonstrated that possibly only one copy of the BAC was 
randomly integrated in the mouse ES cell genome. 
Western blots of Cxxc1-, Men1-, Ptip- and Wdr82-eGFP BAC transgenic 
and targeted lines also showed the expression of the tagged proteins (Fig. 
17). Except for some Wdr82-eGFP BAC transgenic lines, all the clones 
showed signals of the correct molecular weight (Cxxc1-eGFP  106 KDa, 
Men1-eGFP  111 KDa, Ptip-eGFP  154 KDa and Wdr82-eGFP  70 
KDa). Protein extracts from a wild type GFP mock line were always used as 
negative control. Ash2l-eGFP lysates were loaded as positive control in 
Cxxc1, Men1 and Ptip Western blots. Notably, Ash2l can be alternatively 
spliced (Wang et al., 2001), giving rise to the two isoforms detected by 
Western blot. However, the two Ash2l isoforms are not always 
simultaneously expressed as demonstrated in Figure 16. 
Taken together, these results demonstrate that (i) the BAC and targeting 
constructs are fully functional, and (ii) the Long Range PCR screening is 
sufficient to select for correct targeting events. 
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Fig. 17.  Western blot analysis of mouse ES cells probed with an anti-GFP antibody.  PVDF 
membranes containing protein extract from Cxxc1, Men1, Ptip and Wdr82 BAC transgenic and 
targeted mouse ES cell lines were analyzed for the expression of the fusion proteins. Arrows 
represent signals of the correct molecular weight. Ash2l-eGFP isoform 1 = 106 KDa, Ash2l-eGFP 
isoform 2 = 99 KDa. 
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4.6. Localization of the GFP tagged histone H3K4 
methyltransferase complex-specific subunits 
 
In order to understand if the tag interferes with the correct localization of the 
proteins, Ash2l-, Cxxc1-, Men1-, Ptip- and Wdr82-eGFP BAC transgenic 
and targeted cell lines were imaged on glass coverslips by confocal 
microscopy, showing a nuclear localization of the tagged proteins (Fig. 18 
A, B, C). Interestingly, fluorescence intensity of targeted and BAC 
transgenic lines was comparable, leading to the conclusion that BAC 
functional integrations into the genome did not produce a high 
overexpression of the tagged proteins. None of the cell lines except Ptip 
targeted and BAC transgenic lines (Fig. 18 C) showed the presence of the 
tagged protein during mitosis. Ptip seems to be clearly bound to chromatin 
during the cell cycle progression.  
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Fig. 18. Illustrative fluorescence images of the H3K4 methyltransferase complex-specific 
subunits. (A) Ash2l- and Cxxc1-eGFP targeted and BAC transgenic cell lines. (B) Men1- and 
Wdr82-eGFP targeted and BAC transgenic cell lines. (C) Ptip-eGFP targeted and BAC transgenic 
cell lines. 
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4.7. Protein immunoprecipitation of the tagged subunits 
 
Whole protein extracts from 106 cells were prepared from eGFP expressing 
cell lines to check the performance of the immunoprecipitation assay using 
the tagged subunits.  As fluorescence emission and signals on Western 
blots were comparable between targeted and BAC transgenic lines, only 
targeted cell lines were chosen for this pilot test.  
After immunoprecipitation, immunocomplexes were analyzed by Western 
blot and probed with the anti-GFP antibody, showing that all the fusion 
proteins were successfully immunoprecipitated (Fig. 19). 
 
  
Fig. 19. Immunoprecipitation of the targeted eGFP expressing lines. Protein samples were 
loaded in 10% polyacrylamide gel, transferred in a PVDF membrane and probed with the anti-GFP 
antibody. Ash2l-eGFP isoform 1 = 106 KDa; Ash2l-eGFP isoform 2 = 99 KDa; Cxxc1-eGFP  106 
KDa; Men1-eGFP  111 KDa; Ptip-eGFP  154 KDa; Wdr82-eGFP  70 KDa. 
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4.8. Mass Spectrometry analysis of the H3K4 
methyltransferases complex subunits 
 
Mass Spectrometry (MS) is a powerful technique for identification of 
protein–protein interactions and for elucidating components of multiprotein 
complexes. Although MS is highly sensitive and relatively tolerant of 
heterogeneities and contaminants, the identification of protein complexes 
remains a significant challenge. Affinity purification strategies label free or 
combined with isotope labeling strategies such as SILAC (Stable Isotope 
Labeling of Amino acids in Cell culture) have been described for the 
analysis of protein interactions (Hubner and Mann, 2010; Ong et al., 2002). 
In this work, big scale immunoprecipitations (IPs) followed by Mass 
Spectrometry analysis were performed by Prof. Mathias Mann's research 
group (Max Planck Institute of Biochemistry, Martinsried, Germany), using a 
label free approach (Hubner et al., 2010). 
Mass Spectrometry was performed on protein extracts of targeted cell lines 
and identified almost all the known protein interactors for each complex plus 
a certain number of new and unique interactors (Fig. 20). All the complex-
specific subunits could correctly immunoprecipitate those H3K4 
methyltransferases of which they are unique for. Nevertheless, no peptides 
were found for Mll3 in any of the pull downs, likely due to its low expression 
level in mouse ES cells (unpublished data). These results demonstrate that 
the GFP tag does not alter the ability of the protein to bind its protein 
partners. A comprehensive list of all the protein interactors found in the pull 
downs is reported in Table 3. Proteins were divided in four categories: (i) 
core subunits; (ii) H3K4 methyltransferases; (iii) common subunits, including 
known plus new interactors found by Mass Spectrometry; (iv) unique 
subunits. 
 
Cxxc1 has been demonstrated to be part of Setd1a/b complexes (Lee and 
Skalnik, 2005). Interestingly, Cxxc1-eGFP appeared to immunoprecipitate 
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Mll2 (Wbp7). This result possibly indicates a cross-talk between Setd1a/b 
and Mll2 complexes. 
Ptip-eGFP was previously shown to bind chromatin at mitotic figures. 
Notably, Mass Spectrometry showed the presence of proteins responsible 
for telomere assembly and maintenance such as Acd, Terf1 and Tinf2 
(Terf2).  
Remarkably, Wdr82 exhibited interaction with some components of the 
PTW/PP1 complex (Ppp1ca, Ppp1cb, Ppp1r10 and Tox4). 
Ptip and Wdr82 pull downs both showed the presence of PAF complex 
members such as Paf1, Ctr9 and Leo1, known to be involved in ES cells 
cell identity determination (Ding et al., 2009). Taken together, these results 
likely demonstrate that Sed1a/b and Mll3/4 are involved in the complex 
machinery responsible for pluripotency maintenance in ES cells as well. 
Hence, Wdr82 interacts with different protein complexes, underlining a 
possible function of Wdr82 in a variety of cellular processes. 
However, several unique proteins were also found by Mass Spectrometry of 
the complex-specific subunits. Some of them will be further analyzed, such 
as Zscan4f and Zcchc10, belonging to the zinc finger DNA binding proteins 
group. 
In addition, a variety of possible new protein interactors, common to more 
than one H3K4 methyltransferase complex, was found. In this work the two 
proteins, A230054D04Rik (Bod1l) and Dppa5a, were chosen for further 
investigation. 
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Fig. 20. MaxQuant plots of the tagged subunits Mass Spectrometry. The logarithmic ratios of 
protein intensities (x axis) are plotted against negative logarithmic p-values of the t test performed 
from triplicates (y axis). The hyperbolic curve separates specifically interacting proteins marked in 
black (red dotted line) from background (blue dots). The higher the logarithmic ratios of protein 
intensities and the p-values, the more "significant" the result is, in the sense of statistical significance. 
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 log2(Ratio pulldown/control) 
 Ash2l Cxxc1 Men
1 
Ptip Wdr82 
CORE SUBUNITS      
      
ASH2L 7.354 7.400 5.36
5 
4.286 5.499 
DPY30 5.493 5.899 4.24
9 
/ 3.420 
RBBP5 4.221 4.36 2.18 1.640 / 
WDR5 1.970 2.96 0.63
0 
0.890 0.704 
      
H3K4 METHYLTRANSFERASES      
      
MLL1 0.330 / 0.33
3 
/ / 
MLL2 (WBP7) 5.000 3.864 5.53
5 
/ / 
MLL3 / / / / / 
MLL4 (MLL2) 4.718 / / 5.341 / 
SETD1A 5.198 7.938 / / 6.400 
SETD1B 4.240 6.732 / / / 
      
COMMON SUBUNITS      
A230054D04RIK 3.972 6.777 / / / 
DPPA5A 3.840 3.679 3.69
6 
3.713 3.923 
EG667568 6.637 3.059 4.34
0 
/ / 
LEO1 / / / 3.302 4.737 
CTNND1 3.573 / / 3.270 / 
PPP2R2A / 3.059 3.37
2 
3.474 / 
DECR1 / / 3.89
0 
/ 5.087 
FSCN1 / 2.970 3.51
6 
6.348 / 
MYO18A / 4.178 / 5.698 / 
PFKL / / 3.56
4 
/ 3.795 
GTF2E2 / 3.700 / 3.719 / 
CHCHD3 / 3.793 / 5.959 / 
HCFC1 / 4.924 / / / 
PTIP 4.557 / 5.18
6 
7.998 / 
MEN1 / / 6.76
7 
/ / 
WDR82 / 4.019 / / 5.137 
CXXC1 / 8.361 / / / 
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 log2(Ratio pulldown/control) 
 Ash2l Cxxc1 Men1 
Ptip Wdr82 
 
UNIQUE PROTEINS 
     
 ZSCAN4F 
(6.220
) 
CAPRIN2 
(2.809) 
CST
F3 
(4.1
87) 
ACD 
(3.704) 
CTR9 
(4.663) 
 POL (5.273
) 
DAZL 
(4.135) 
RO
D1 
(4.5
81) 
ALPL 
(4.101) 
NMT1 
(4.227) 
 NAIP3 (3.816
) 
HSD17B10 
(3.937) 
 BST2 
(3.385) 
PAF1 
(5.007) 
 L1MD-TF29 
(4.872
) 
  C1QBP 
(3.634) 
PCID2 
(3.327) 
    CBLL1 (3.440) 
PPP1CA 
(5.958) 
    CKAP4 (3.575) 
PPP1CB 
(3.543) 
    DBN1 (5.671) 
PPP1R10 
(4.104) 
    DCAKD (3.660) 
TOX4 
(7.341) 
    FLNA (3.969) 
TXLNA 
(3.745) 
    KDM6A (3.735) 
 
    PA1 (5.124) 
 
    PSPC1 (3.165) 
 
    SPTBN1 
(4.450) 
 
    STOML2 
(4.435) 
 
    TERF1 (4.237) 
 
    TINF2 (4.303) 
 
    TTC14 (3.375) 
 
    ZCCHC10 
(4.608) 
 
 
Table 3. List of protein interactors found by immunoprecipitation of the GFP tagged subunits. 
Significant values for the proteins are expressed in log2 (Ratio pulldown/control). 
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4.9. Bod1l and Dppa5a protein analysis  
 
Mass Spectrometry enlightened some possible new protein interactors of 
the H3K4 methyltransferase complexes. Additional analyses were focused 
on Dppa5a and Bod1l. 
Dppa5a encodes a polypeptide of 118 amino acids that contains a single 
KH domain (Fig. 21), which is an RNA-binding domain (Gibson et al., 1993).  
 
 
Fig. 21. SMART sequence analysis of Dppa5a protein (118 aa). The KH RNA binding domain is 
located between aa 21 and aa 91, according to the SMART domain prediction. 
 
 
Protein domain structure prediction of the Bod1l sequence using different 
databases highlighted the presence of an Sgh1 domain, coiled coils and 
AT-hooks (Fig. 21). 
 
 
 
Fig. 21. Domain Structure of Bod1l. Bod1l consists of a Shg1 domain, some coiled coils and two 
AT hooks. 
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Protein alignments confirmed that Bod1l is homolog to other known proteins 
(Fig. 22). The alignments showed that the Pfam Family: PF05205 contains 
both the yeast Shg1 and Bod1l proteins. 
 
 
Fig. 22. Alignment of the N terminal conserved parts of Shg1 and Bod1 family proteins. The 
upper part (blue) of the alignment is the seed alignment from the Pfam: PF05205 family. The lower 
part (red) is the alignment of a selected set of Bod1 proteins, including human Bod1l (ortholog of our 
murine Q80TF0_MOUSE MKIAA1327, which is a partial sequence). The Pfam alignment contains 
some metazoan sequences, including those from Zebrafish, Xenopus and Nematostella. These 
sequences were used as guides for the two alignments. 
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4.10. Tagging of the new interactors Bod1l and Dppa5a 
 
Bod1l and Dppa5a were C-terminally tagged with a simple mVenus/YFP tag 
by recombineering (Fig. 23).   
 
 
Fig. 23. Modular structure of the Venus tagging cassette inserted into Bod1l and Dppa5a 
BACs. 
 
Successful recombinants were verified by restriction enzyme digestion (Fig. 
24). The analyzed BAC clones showed the correct restriction pattern 
according to the GCK predictions and were sequenced to confirm the 
5’junction sequence. 
 
 
Fig. 24. Restriction digest patterns of recombinant clones. (A) Dppa5a BACs digested with NcoI. 
(B) Bod1l BAC digested with NdeI. Appearance of an additional band compared to wild type BAC is 
shown by an arrow. 
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4.11. Bod1l and Dppa5a expression in mouse ES cells 
 
BAC constructs were transfected in undifferentiated mouse ES cells. After 
selection, G418 resistant colonies were picked and expanded. Whole cell 
protein extracts were prepared and used for Western Blot analysis.  
Membranes were probed with an anti-GFP antibody and chemiluminescent 
signals of the correct molecular weight were detected for both Dppa5a and 
Bod1l (Fig. 25).  
Specifically, three Bod1l clones out of six showed a sufficient expression of 
the protein with a band at 360 kDa, whereas all the Dppa5a BAC 
transgenic clones exhibited an adequate expression of the  44 kDa fusion 
protein. 
 
 
Fig. 25. Western Blots of Bod1l and Dppa5a clones. Proteins with the correct molecular weight 
are indicated with an arrow. 
 
 
4.12. Bod1l and Dppa5a cellular localization in mouse ES 
cells 
 
To visualize the protein localization, Bod1l- and Dppa5a-mVenus were 
imaged by confocal microscopy (Fig. 26). Bod1l showed a nuclear 
localization and no binding to the chromatin during mitosis.  In contrast, 
Dppa5a demonstrated to almost exclusively localize into the cytoplasm as 
described in the literature and very little into the nuclei. 
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Fig. 26. Fluorescence analysis of some BAC transgenic Dppa5a- and Bod1l mVenus clones. 
 
 
4.13. Bod1l and Dppa5a protein immunoprecipitation 
 
In order to prove that Bod1l or Dppa5a are part of one of the H3K4 
methyltransferase complexes, whole protein lysates were prepared from 
106 cells and used for protein immunoprecipitation with the GFP antibody.  
Immunocomplexes were analyzed by Western blot. The membrane was 
probed with the anti-Ash2l antibody (Fig. 27). Total proteins from wild type 
E14tg2a, Ash2l- and Cxxc1-eGFP BAC transgenic lines were used as 
positive controls. Immunoprecipitation was also performed with the mock 
E14tg2a line as negative control. 
The Western blot showed that Bod1l does immunoprecipitate both isoforms 
of Ash2l, as in the control lanes for Cxxc1-eGFP and total proteins samples.  
However, Dppa5a did not show the specific band for Ash2l protein. 
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These results suggest that at least Bod1l is likely part of the Setd1a/b H3K4 
methyltransferase complexes. Bod1l will be subjected to Mass 
Spectrometry to finally confirm our early results.  
Although Dppa5a did not seem to pull down Ash2l, Mass Spectrometry 
analysis will be performed as well.  
 
  
 
Fig. 27. Western blot of Bod1l- and Dppa5a-YFP pull downs. Signal corresponding to Ash2l 
isoform 1 and isoform 2 are respectively represented with a blue and a red arrow. Ash2l isoform 1 = 
68 KDa, Ash2l isoform 2 = 61 KDa. Ash2l-eGFP isoform 1 = 106 KDa, Ash2l-eGFP isoform 2 = 99 
KDa. 
 
4.14. ChIP assay of the H3K4 methyltransferase 
complexes 
 
Chromatin immunoprecipitation followed by deep sequencing of the 
immunoprecipitated DNA was performed with targeted eGFP knock-in 
mouse ES cell lines to understand the genomic elements through which the 
H3K4 methyltransferases exerts their functions.  
Chromatin of Ash2l-, Cxxc1-, Men1-, Ptip- and Wdr82-eGFP mouse ES 
cells was crosslinked with formaldehyde and immunoprecipitated with 
protein A/G agarose beads. Immunoprecipitated DNA was checked with 
specific primer pairs of known or potential target genes (Brca1, Magohb, 
Eno3) in qPCR assays. Each PCR was performed on immunoprecipitated 
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wild type ES cell DNA in parallel, thus providing a control for background 
level. The immunoprecipitated DNA was also used as PCR template for an 
extragenic locus of chromosome nine to exclude the chance the PCR 
product might be generated by unspecifically immunoprecipitated 
chromatin, which often occurs in chromatin immunoprecipitation 
experiments. The ratio between the experimental and the control signal for 
chromosome nine was divided by the respective ratio for the input DNA.  
The same kind of analysis was done on wild type control to compare fold 
enrichment of the sample versus background. A summary of the fusion 
proteins fold enrichment at their specific loci is showed in Figure 28.  
Overall, the entire set of tagged proteins demonstrated a good enrichment 
at the respective target sequences, ranging from 25.6 to 98.3%. In 
particular, Ash2l appeared strongly bound to Magohb promoter with a signal 
intensity  100 fold higher than the control DNA. Taken together, these 
results demonstrated that the immunoprecipitated chromatin was suitable 
for deep sequencing analysis. 
 
 
Fig. 28. qPCR analysis of the enrichment of the tagged proteins at target loci. qPCR were 
performed with 1:10 diluted immunoprecipitated DNA and 1:500 diluted input DNA. Fold enrichment 
at target loci were obtained by normalizing the sample on the ct values of the chromosome 9 
extragenic region and input. 
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4.14.1. Genome-wide ChIP-seq analysis 
 
Genome-wide sequencing of the immunoprecipitated DNA was performed 
by Illumina Solexa's sequencing-by-synthesis chemistry. Image files 
generated by the Illumina Genome Analyzer were subjected to high-
resolution image processing and converted to intensity files for base calling. 
Sequence alignment against the mm9 reference genome was performed 
with alignment program ELAND, which includes an efficient and fast 
algorithm suitable for short reads. After sequenced reads were aligned to 
the reference genome, enriched regions in the ChIP sample relative to the 
control with statistical significance were identified with the peak caller 
software FindPeaks. UCSC genome browser was used to display the 
coverage from both the ChIP and control samples.  Preliminary alignment of 
the reads against the mouse genome showed that all the chromatin 
preparations with the exception of Men1-eGFP were properly done (Fig. 
29). A particularly high coverage of the reads was found in chromosome 
eight and nine for all the chromatin preparations. In this work, H3K4me3 
and H3K27me3 data sets were included to have a reference for active and 
repressed genes respectively. In addition the two histone marks were used 
to localize bivalent promoters and visualize the binding pattern of the H3K4 
methyltransferases at these regulatory sequences. Since Men1-eGFP 
ChIP-seq failed, Dr. Helmut Hofemeister (Biotec TU, Dresden) provided a 
ChIP-seq data set generated after immunoprecipitation of Mll2 
methyltransferase internally tagged with GFP to use as a reference at least 
for the Mll2 complex (unpublished data).  
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Fig. 29.  Mapping of the ChIP-seq reads to the mouse genome. 
 
Representative images obtained from UCSC genome browser were used to 
display the binding sites at specific promoters.  
In order to check whether correct ChIP maps were generated, an image of 
the binding pattern on the known Mll2 target gene Magohb/2010012C16Rik 
(Lubitz et al., 2007) was produced for all the tagged subunits (Fig. 30). 
Magohb is involved in mRNA splicing and in the nonsense-mediated decay 
(NMD) pathway. The protein interacts with RBM8A and is part of the exon 
junction complex (EJC) containing NCBP1, NCBP2, RNPS1, RBM8A, 
SRRM1, NXF1, UPF3B, UPF2 and THOC4. It remains associated with the 
mRNA after its export to the cytoplasm and requires translation of the 
mRNA for removal.  
In our experiment, no peaks were detected for control sample, E14tg2a 
eGFP mock.  As expected, Mll2 showed binding the H3K4me3 marked CpG 
island promoter of the Magohb gene.  Being part of H3K4 methyltransferase 
core complex, Ash2l appeared also to bind Magohb promoter. Furthermore, 
Cxxc1 was previously demonstrated to pull down Mll2 methyltransferase 
together with its known interacting H3K4 methyltransferases Setd1a and 
Setd1b. Therefore, Cxxc1 cross-interaction with Mll2 complex might explain 
its high coverage at Magohb promoter. Binding of Ptip (Mll3/4 specific 
subunit) at Magohb promoter was not significant. A low peak was detected 
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for Wdr82. These results suggest that Mll2 and Setd1a/b complexes might 
collaborate in the regulation of this gene.  
 
 
Fig. 30. Representative image obtained from UCSC genome browser displaying the binding 
sites at the MagohB promoters. 
1 = Ash2l-eGFP reads. 2 = Cxxc1-eGFP reads. 3 = Mll2-eGFP reads. 4 = Ptip-eGFP reads. 5 = 
Wdr82-eGFP reads. 6 = E14tg2a eGFP mock reads. 7 = H3K4me3 reads. 8 = H3K27me3-eGFP 
reads.  
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4.14.2. Coverage of the tagged subunits at the H3K4 
methyltransferase promoters   
 
A basic question we tried to address was: do different H3K4 
methyltransferases reciprocally regulate their own promoter regions?  
Illustrative UCSC snapshots of the H3K4 methyltransferase promoters were 
analyzed (Fig. 31). In general, each of the complex-specific subunits was 
found at the different promoter regions of the H3K4 methyltransferases, with 
the exception of Ptip, which did not show very high coverage. No peaks 
were displayed for the control sample. These results demonstrated that all 
the H3K4 methyltransferases except Mll4 complex components cross-
regulate each other.  
 
Fig. 31.  Promoter regions of the H3K4 methyltransferase.  
1 = Ash2l-eGFP reads. 2 = Cxxc1-eGFP reads. 3 = Men1-eGFP reads. 4 = Ptip-eGFP reads. 5 = 
Wdr82-eGFP reads. 6 = E14tg2a eGFP mock reads. 7 = Mll2- eGFP reads. 8 =. H3K27me3-eGFP 
reads 9 = H3K4me3 reads. 
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4.14.3. Role of the H3K4 methyltransferases in the 
regulation of pluripotency markers 
 
Mass Spectrometry data showed that some of the H3K4 methyltranferases 
complexes interacted with proteins involved in ES cell identity. 
Consequently, regulation of pluripotency markers such as Nanog was 
checked at the promoter level (Fig. 32).  
 
 
Fig. 32. Representative UCSC picture displaying the coverage of the tagged proteins at the 
Nanog regulatory regions. 
1 = Ash2l-eGFP reads. 2 = Cxxc1-eGFP reads. 3 = Men1-eGFP reads. 4 = Ptip-eGFP reads. 5 = 
Wdr82-eGFP reads. 6 = E14tg2a eGFP mock reads. 7 = Mll2- eGFP reads. 8 =. H3K27me3-eGFP 
reads 9 = H3K4me3 reads. 
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Wdr82 and Ptip showed high coverage on both enhancer and promoter 
regions of the Nanog gene, suggesting that Setd1a/b and Mll3/4 complexes 
might be involved in regulation of pluripotency state in ES cells, as already 
proposed after Mass Spectrometry data analysis. Again, Ash2l showed a 
strong binding at regulatory regions as a core component of H3K4 
methyltransferase complexes. 
 
Members of the Paf complex were found to interact with Wdr82 and Ptip by 
Mass Spectrometry data. Binding of Setd1a/b complexes at Paf1 promoter 
was confirmed by Wdr82 and Cxxc1 peaks at the above-mentioned locus 
(Fig. 33).   
Significant reads were detected for Ptip sample only on one out of the two 
sequence elements of Paf1 promoter marked with H3K4me3. In addition, 
Ash2l showed significant coverage at Paf1 promoter as core subunit of 
each H3K4 methyltransferase complex. 
These evidences support the hypothesis that Mll3/4 and Setd1a/b 
complexes might have a role in Paf1 gene expression. Likely, this 
regulatory circuit has an impact on the maintainance of ES cells 
pluripotency. 
Overall, Ash2l apparently seems to bind all the active genes in mouse ES 
cells, as it is always present at regulatory regions with H3K4me3 mark.  
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Fig. 33. UCSC ChIP-seq profile at the Paf1 promoter. 
1 = Ash2l-eGFP reads. 2 = Cxxc1-eGFP reads. 3 = Men1-eGFP reads. 4 = Ptip-eGFP reads. 5 = 
Wdr82-eGFP reads. 6 = E14tg2a eGFP mock reads. 7 = Mll2- eGFP reads. 8 =. H3K27me3-eGFP 
reads 9 = H3K4me3 reads. 
 
 
4.14.4. Regulation of Bod1l gene expression by H3K4 
methylation 
 
Proteomic data showed a likely new protein interactor of Setd1a/b 
complexes, Bod1l. As already described, protein alignment highlighted it as 
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mouse ortholog of the yeast Shg1. Regulation of the Bod1l gene driven by 
H3K4 methyltransferases was verified at the specific locus (Fig. 34). 
Interestingly, the complex-specific subunits demonstrated to bind Bod1l 
promoter.  
 
Fig. 34.  Representative image obtained from UCSC genome browser displaying the binding 
sites at the Bod1l promoter. 
1 = Ash2l-eGFP reads. 2 = Cxxc1-eGFP reads. 3 = Men1-eGFP reads. 4 = Ptip-eGFP reads. 5 = 
Wdr82-eGFP reads. 6 = E14tg2a eGFP mock reads. 7 = Mll2- eGFP reads. 8 =. H3K27me3-eGFP 
reads 9 = H3K4me3 reads.  
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4.14.5. Outlook of bivalent promoters 
 
Our group has developed the hypothesis that only the H3K4 
methyltransferase Mll2 is able to bind regulatory elements with both marks, 
H3K4me3 and H3K27me, the so-called bivalent regions. In order to confirm 
our hypothesis we analyzed H3K4 methyltransferase complexes binding 
pattern at bivalent promoters. As an illustrative example, the promoter of the 
Sfrp5 gene was examined. Sfrp5 gene encodes the secreted frizzled-
related sequence protein 5 (Fig. 35). Sfrp5 is an inhibitory factor of Wnt 
signaling and expressed in the foregut endoderm of the primitive gut tube of 
E8.5 embryo and later in pancreatic and liver bud of E9.5 embryo (Finley et 
al., 2003). Sfrp5 and all the other analyzed promoters showed that only Mll2 
and Ash2l (as a core subunit of the complex) demonstrated a significant 
binding, supporting our assumption.  
 
Fig. 35. Representative image obtained from UCSC genome browser displaying the binding 
sites at the Sfrp5 promoter. 
1 = Ash2l-eGFP reads. 2 = Cxxc1-eGFP reads. 3 = Men1-eGFP reads. 4 = Ptip-eGFP reads. 5 = 
Wdr82-eGFP reads. 6 = E14tg2a eGFP mock reads. 7 = Mll2- eGFP reads. 8 =. H3K27me3-eGFP 
reads 9 = H3K4me3 reads. 
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We are currently trying to perform more extensive analyses by comparing 
the ChIP-seq datasets acquired from some GFP knock in ES cell lines to 
the ChiP-seq datasets obtained from some H3K4 methyltransferase knock 
out ES cell lines. A hierarchical clustering of Mll2-eGFP ChIP-seq reads 
together with the tagged complex-specific subunits Ash2l and Cxxc1 on 
promoters (Fig. 36) has been produced by Dr. Sergey Denissov from Prof. 
Henk Stunnenberg’s group (Nijmegen Centre for Molecular Life Sciences, 
Nijmegen, Netherlands; unpublished data). Constitutive Mll1 and Mll2 knock 
out cell lines (generated by Dr. Kostantinos Anastassiadis and Dr. Sandra 
Lubitz, Biotec TU, Dresden) and the conditional Mll2 knock out cell lines 
(produced by Dr. Konstantinos Anastassiadis, Dr. Helmut Hofemeister and 
Dr. Andrea Kranz, Biotec TU, Dresden), were used for ChIP-seq experiment 
with an anti-H3K4me3 antibody upon tamoxifen induction to remove the 
critical exon. H3K27me3 immunoprecipitation was performed in        
parallel. In the wild type E14tg2a sample, that set of promoters with both 
H3K4me3 and H3K27me3 marks represents the bivalent fraction of 
promoters.  
By comparing the wild type E14tg2a sample to the Mll2 knock outs, loss of 
H3K4me3 mark but not H3K27me3 mark was detected at bivalent 
promoters after Mll2 removal (Fig. 36 A). No effect on promoters was 
observed upon Mll1 removal. Interestingly, Mll2 constitutive knock out 
sample showed a more than 2.5 fold reduction of H3K4me3 marks 
compared to the Mll2 conditional knock out sample, whereas H3K27me3 
results were unaltered (Fig. 36 F). In the subset of promoters unaffected by 
Mll2 loss, no change in H3K4me3 or H3K27me3 was observed (Fig. 36 G). 
A good concordance with the expression profile sequencing data performed 
on constitutive Mll2 knock out line was found, as no reads were found on 
the genes with bivalent signature (Fig. 36 D). Notably, bivalent promoters 
represent a small subset of the whole genome, and most of them belong to 
developmental genes (Fig. 36 C). Interestingly, a subset of bivalent 
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promoters seems to be occupied by Mll2 complex only, which includes 
Ash2l as core component, but not by Setd1a/b complexes, represented by 
Cxxc1 (Fig. 36 E). More extensive statistical analyses of the ChIP-seq data 
are currently ongoing. 
 
Fig. 36. Clustering of Ash2l, Cxxc1, Wdr82 and Mll2 ChIP-seq data sets. (A) Clustering of of Mll1 
and Mll2 constitutive (sMll2 KO) and conditional (iMll2tam) double knock-out samples versus controls 
immunoprecipitated with an anti-H3K4me3 antibody and subsequent ratios sample/control to 
underline changes of H3K4me3 mark at promoter regions. (B) Clustering Mll2 constitutive (sMll2 KO) 
and conditional (iMll2tam) double knock out samples versus controls immunoprecipitated with an 
anti-H3K27me3 antibody. (C) Clustering of bivalent promoters. (D) RNA expression profile of the 
constitutive Mll2 double knock out sample versus control. (A) Comparison between different GFP 
tagged transgenes ChIP-seq data sets. (F) Estimation of the loss of H3K4me3 and H3K27me3 in the 
subset of bivalent promoters. (G) Estimation of the loss of H3K4me3 and H3K27me3 in the subset of 
promoters unaffected by Mll2 removal.  
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5. Discussion 
 
5.1. Generation, expression and functional tests of the 
H3K4 methyltransferase complex-specific tagged 
components 
 
A major problem with proteomic research involves the need to either find or 
generate a good specific antibody for a protein that can be used for various 
protein-specific biochemical methods (e.g. immunoprecipitation in ChIP or 
Mass Spectrometry or immunofluorescence). 
Protein tagging offers many advantages for proteomic and regulomic 
research. Ideally, protein tagging is equivalent to a high affinity antibody for 
every chosen protein. However, these advantages are compromised if the 
tagged protein is overexpressed, which is usually the case from cDNA 
expression vectors. Physiological expression of tagged proteins can be 
achieved by gene targeting to knock-in the protein tag or by BAC 
transgenesis. BAC transgenes usually retain the native gene architecture 
including all cis-regulatory elements as well as the exon-intron 
configurations. Consequently most BAC transgenes are authentically 
regulated (e.g. by transcription factors, cell cycle regulators, miRNA) and 
can be alternatively spliced. Recombineering has become the method of 
choice for generating targeting constructs or modifying BACs.  
Protein tagging has been very successful in yeast, particularly with the large 
TAP tag (Gavin et al., 2006; Krogan et al., 2006; Shevchenko et al., 2009). 
More than two-thirds of yeast open reading frames have been TAP tagged 
on the C-terminus by knock-in gene targeting. About 85% of them have 
been successfully immunoprecipitated using a generic protocol (Rigaut et 
al., 1999; Pijnappel et al., 2001). This success rate is notable because the 
average size of yeast proteins is about the same size as the TAP tag.  
 95 
The acquired protein interaction data has established the most 
comprehensive and accurate proteomic map for many cell types (Collins et 
al., 2007; Royer et al., 2010). After all the achievements reached in yeast 
research, systems biology in mammals has moved in the same direction in 
order to carry out proteomic and regulomic investigations on a large scale to 
decipher the underlying regulatory networks.  
Embryonic stem (ES) cells are derived from the inner cell mass of the 
preimplantation embryo and are pluripotent, and therefore are able to 
differentiate into all cell types of the adult organism. Once established from 
mice, the pluripotent ES cells can be maintained under defined culture 
conditions, and can also be induced rapidly to differentiate. Maintaining this 
balance of stability versus plasticity is a challenge, and extensive studies in 
recent years have focused on understanding the contributions of 
transcription factors and epigenetic enzymes to the “stemness” properties of 
these cells. Identifying the molecular switches that regulate ES cell self-
renewal versus differentiation can provide insights into the nature of the 
pluripotent state and enhance the potential use of these cells in therapeutic 
applications. Although there has been remarkable progress in defining the 
growth requirements for the maintenance and differentiation of ES and 
other stem cells, attempts to define predictive molecular signatures have 
proved difficult, and have given only limited information on how lineage 
restriction is achieved.  
Protein tagging represents a powerful approach to fulfill the lack of 
information about the epigenetic regulation of ES cells. 
Histone tail modifications and particularly trimethylation of H3K4, denoting 
an active state of the chromatin, are important marks that play a major role 
in the epigenetic regulation of ES cells. In mammalian cells six different 
H3K4 methytransferases functioning in protein complexes are responsible 
for placing this mark on the histone tails: Setd1a, Setd1b, Mll1, Mll2, Mll3 
and Mll4. All these histone methyltransferses are commonly large proteins 
and often sensitive to degradation. Consequently, immunoprecipitation 
 96 
assays requiring a sonication step or long incubation times are difficult to 
achieve. Because of these issues, we constructed GFP tagged versions of 
complex-specific subunits for BAC transgenesis and gene targeting.  
We generated BAC transgenic and targeted eGFP expressing ES cell lines 
for the shared complex component Ash2l and the unique complex subunits 
Cxxc1 and Wdr82 (Setd1a/b complexes), Men1 (Mll1/2 complexes), Ptip 
(Mll3/Mll4 complexes). BAC transgenesis was efficient and produced for all 
constructs at least 50% of GFP expressing clones. Interestingly, targeted 
cell lines clones, screened by long range PCR, demonstrated the 
expression of the fusion protein as well. Thus, we showed that long range 
PCR might be an appropriate alternative approach to Southern Blot. 
Targeting efficiencies based on long range PCR screening were reasonable 
with the only exception of Cxxc1. In general both BAC transgenic and 
targeted lines showed a strong expression of the fusion protein, proving that 
the constructs were fully functional and our recombineering pipeline for 
tagging is effective. Remarkably, the comparison between BAC transgenic 
and targeted clones on Western blots by using the same amount of protein 
lysates for each experiment showed that BAC transgenesis did not 
generate multiple functional integrations into the genome, resulting in 
expression level of the BAC transgene that are similar to the targeted allele. 
Although physiological expression of the protein by gene targeting is 
desirable, in this work we showed that BAC transgenesis might be an 
easier, more advantageous and faster option for at least three reasons: (i) 
producing a BAC transgene requires only one recombineering step; (ii) 
transfection of the construct and selection of the clones is much less 
laborious, as no genotyping step is involved in the procedure; (iii) a 
reasonable physiological expression of the protein is achieved. 
Genetically encoded tags such as GFP are widely used to monitor discrete 
proteins. However, tags can cause significant perturbations to a protein's 
structure and consequently to its function. We performed functional tests to 
understand whether the protein's function was preserved. Specifically, we 
 97 
first ran a pilot experiment to check the performance of our tagged proteins 
in protein immunoprecipitation assays. Considering that the difference in 
protein expression level between BAC transgenic and targeted lines was 
minor, we only employed targeted cell lines to perform this analysis, as they 
are physiologically expressed. The protein immunoprecipitations revealed 
that the GFP tag allows efficient pull down of the H3K4 methyltransferase 
complex components. Therefore, the same lines were subjected to Mass 
Spectrometry analysis. The H3K4 methyltransferase complex subunits were 
able to pull down the majority of the factors shared by all the H3K4 
methyltransferase complexes with statistically significant values. Overall, we 
demonstrated that GFP did not modify the ability of the tagged proteins to 
associate in multiprotein complexes. Nevertheless, some of the shared 
modules were missing, likely due to the high stringency of the MaxQuant 
software analysis. Furthermore, each complex-specific subunit was able to 
immunoprecipitate its respective H3K4 methyltransferase. However, Mll3 
was not detected in Ptip pull down. This is probably due to the low 
expression level of this protein in ES cells (unpublished data). 
Hence, our tagging strategies demonstrated to be a suitable and sensible 
method to study H3K4 methylation dynamics. 
 
5.2. Cellular localization of the GFP/YFP tagged proteins 
and their regulation of the cell cycle 
 
Knowledge of protein localization can provide a wealth of information about 
its function, activation state and interactions with other molecules. Given the 
compartmentalization of eukaryotic cells, localization of a protein is typically 
related to its function and can therefore be an important step towards the 
full understanding of its physiological role. Ideally, localization data indicates 
not only the compartment where a protein is found, but also changes in 
localization during the different physiological stages of the cell.  
Variations in localization may result from cell signaling events, 
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environmental changes and progression through the cell cycle. Recently 
many techniques, including immunocytochemistry at the light and electron 
level, and subcellular fractionation, have been employed to provide protein 
localization information. The use of light microscopy along with genetically 
encoded fluorescent proteins has transformed localization studies. An 
attractive feature of the GFP protein tagging method is that it allows direct 
visualization of tagged proteins by confocal microscopy, providing crucial 
information about location and trafficking of proteins in vitro and in vivo. 
We analyzed Ash2l-, Cxxc1-, Men1-, Ptip- and Wdr82-eGFP targeted and 
BAC transgenic lines by confocal microscopy and the tagged proteins 
showed a nuclear localization in both configurations, proving that the GFP 
did not alter the cellular localization dynamics of our proteins of interest.  
Interestingly, we found that Ptip binds chromatin in mitotic cells. 
Additionally, we showed by Mass Spectrometry that Ptip interacts with 
proteins involved in cell cycle such as Terf1, Terf2 and Acd. The 
relationship between Ptip and cell cycle might be explained in two ways. 
First, Ptip and Mll3/4 complexes might have a role in the maintenance of 
telomere elongation in mouse ES cells via interaction with Terf1, Terf2 and 
Acd. In mammals, the telomeric repeat binding factors Terf1 and Terf2 
directly bind to double-stranded telomeric DNA. Overexpression of wild type 
Terf1 results in reduction of telomere length, whereas inhibition of Terf1 
increases telomere length. These data have implicated Terf1 in telomere 
length regulation, acting as a negative regulator of telomere length 
(Karlseder, 2003). Overexpression of wild type Terf2 also reduces telomere 
length and its loss leads to unprotected, fusigenic chromosome ends that 
are recognized as double-strand breaks (de Lange, 2002). Other proteins 
known to be associated with telomeres are recruited through their 
interaction with either Terf1 or Terf2, such as Acd, Tankyrase 1 and 2, Tin2, 
Pinx1, Pot1 and Ptop/Pip1 (Hartmanna and Scherthan, 2004). Ptip or Mll3/4 
complexes might be recruited in a similar manner to preserve telomere 
length. Second, the observation that Ptip binds chromatin in mitotic cells 
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might be related to its role in genome stability. Genomic stability in 
eukaryotic cells is maintained by the coordination of multiple cellular events 
including cell cycle checkpoint, DNA repair, transcription, and apoptosis 
after DNA damage. Ptip, a protein that contains six BRCT domains, is 
implicated in the DNA damage response. In particular, Ptip is required for 
cell survival and G2/M checkpoint control after ionizing radiation, and 
indeed phosphorylation of Chk2 and p53 are slightly impaired in the Ptip 
deficient cells. This function of Ptip in DNA damage response might be 
independent of the Mll complexes (Gong et al., 2009). Alternatively, Ptip 
has been found to associate with the relocation of the protein 53BP1 to 
DNA damage sites. The recruitment of 53BP1 to the DNA damage sites is 
also dependent on its Tudor domain that recognizes methylated histones 
(Wu et al., 2009). Notably, Ptip associates with Mll3/Mll4 histone 
methyltransferase complexes. Thus, it is possible that Ptip-dependent 
histone methylation may recruit 53BP1 to the DNA damage sites. 
Wdr82 was previously identified as an integral component of the H3K4 
Setd1a and Setd1b methyltransferase complexes. Our data revealed that 
Wdr82 additionally associates with another protein complex, the PTW/PP1 
phosphatase complex composed of regulatory subunits Ppp1r10, Tox4, and 
Wdr82, and a PP1 catalytic subunit (Lee and Skalnik, 2010), as reported by 
Lee and Skalnik, 2010 (Lee and Skalnik, 2010). PP1 is involved in cell cycle 
progression, especially during mitosis and mitotic exit, and dysregulation of 
PP1 activity causes mitotic arrest or deficient cytokinesis in mammals 
(Ceulemans and Bollen, 2004). Wdr82 may function to recognize 
phosphorylated serine/threonine residues for PP1 action, consistent with 
previous reports that Wdr82 in the Setd1a and Setd1b methyltransferase 
complexes specifically recognizes Ser5-phosphorylated RNA pol II CTD 
(Lee and Skalnik, 2008). Although Wdr82 was not observed to bind mitotic 
chromatin in confocal microscopy assays, our data reveal that Wdr82 might 
have an indirect role in the regulation of chromatin structure during the 
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transition from mitosis into interphase via interaction with the PTW/PP1 
phosphatase complex. 
 
5.3. The novel components of H3K4 methyltransferases 
complexes 
 
Mass Spectrometry highlighted several unknown interactors of the H3K4 
methyltransferase complexes. We chose two of them for further analyses, 
Bod1l and Dppa5a.  
Dppa5a was originally identified as a transcript that was down regulated by 
retinoic acid in embryonic carcinoma cells (Astigiano et al., 1991). The 
expression of this gene is confined to pluripotent cells, including ES cells, 
embryonic germ cells, and multipotent germline stem cells (Kanatsu-
Shinohara et al., 2004; Western et al., 2005). Dppa5a protein is polypeptide 
of 118 amino acids composed of a single KH RNA binding domain (Gibson 
et al., 1993). Dppa5a associates with specific target transcripts such as 
Cdc25a, Cdc42, Ezh2, Nfyc and Nr5a2. Dppa5a is dispensable for mouse 
development, germ cell formation, and ES cell self-renewal (Amano et al., 
2006). It has been reported that Dppa5a shows a nuclear and cytoplasmic 
localization (Western et al., 2005). Bod1l was originally identified by Porter 
and coworkers as a component of the outer kinetochore and spindle poles 
during mitosis, required for chromosome bi-orientations (Porter et al., 2010). 
Porter et al. analyzed Bod1l for its hydrodynamic properties by fractionating 
Hela cell lysates using gel filtration and sedimentation through glycerol 
gradients. The protein lysates were then analyzed with a polyclonal anti-
BOD1 antibody, which recognized two forms: (i) 25 ± 10 KDa protein, which 
isprobably monomeric and is the isoform binding the kinetochore; (ii) 489.6 
± 76 KDa protein that does not seem to interact with Ndc80/Hec1, an 
important component of the kinetochore. Our Mass Spectrometry analyses 
identified the second isoform in Ash2l and Cxxc1 pull downs.  
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Both Bod1l and Dppa5a were tagged and expressed in mouse ES cells in a 
BAC transgenic manner. Dppa5a was found in all the pull downs that we 
performed. Bod1l was instead more restricted, being part only of Ash2l and 
Cxxc1 protein pools. We investigated the cellular localization of Bod1l and 
Dppa5a by confocal microscopy. Unfortunately, Dppa5a did not show a 
consistent nuclear localization and the subsequent protein 
immunoprecipitation did not prove the presence of the shared H3K4 
methyltransferase subunit, Ash2l. Thus, this protein was likely a background 
binder appearing in the protein immunoprecipitation prior to Mass 
Spectrometry. Nevertheless, Mass Spectrometry of Dppa5a will be 
performed to confirm our hypothesis that the protein is not a true interactor 
of the H3K4 methyltransferase complexes. In contrast, we demonstrated 
that Bod1l had a clear nuclear localization and was able to 
immunoprecipitate Ash2l.  This result confirms that Bod1l is part of a H3K4 
methyltransferase complex. We then performed protein alignment of the 
Bod1l sequence. Notably, we found that Bod1l might be the mouse ortholog 
of the yeast Shg1 protein, a subunit of the Set1C complex. Shg1 is a core 
subunit of the yeast SET1 complex (Set1C). Set1C or COMPASS has eight 
subunits: Swd1, Swd2, Swd3, Bre2, Sdc1, Spp1 and Shg1 (Table 1). Only 
one subunit, Swd2, is essential in S. cerevisiae, because it is also a subunit 
of cleavage and a polyadenylation factor (Dehé et al., 2006). Set1C 
methylates H3K4 either to mono-, di-, or trimethylated states. It has been 
reported that Shg1 is not required for the complex assembly and it seems 
that Shg1 slightly inhibits H3K4 di- and trimethylation (Dehé et al., 2006). 
So far, neither report showed the presence of Shg1-like proteins in the 
context of H3K4 methyltransferase complexes. Moreover, Bod1l was 
immunoprecipitated only by Ash2l and Cxxc1, which is consistent with the 
fact that Setd1a and Setd1b are the mammalian orthologs of the yeast 
Set1C. Reciprocal Mass Spectrometry using Bod1l protein to pull down 
Setd1a and Setd1b complexes will be performed soon. In addition, knock 
out alleles of Bod1l gene will be generated in order to observe whether the 
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depletion of the protein causes an increase of H3K4 di- and trimethylation, 
as it has been demonstrated in yeast for Shg1. 
Not surprisingly we found that the H3K4 methyltransferase complexes bind 
the promoter of Bod1l. Regulation of chromatin structure at Bod1l locus 
might be important to maintain a slight inhibitory effect on di- and 
trimethylation of H3K4 as shown in yeast (Dehé et al., 2006).  
 
5.4. Regulation of promoters and pluripotency by H3K4 
methylation 
 
In the last few years the understanding of chromatin structure has increased 
and its attributes at different genomic loci and in various cell types has led 
to the challenge to elucidate which components and regulatory elements 
are involved in the acquisition of a specific structure.  
Particular DNA sequences, transcription factors and other regulatory 
proteins, may define specific chromatin configurations that may be 
maintained through epigenetic controls that are embedded in the chromatin 
machinery. Sequence features such as promoters, CpG islands and 
repetitive elements can adopt characteristic modification patterns and 
chromatin states. 
The complex mechanisms behind these patterns have been intensively 
examined but remains poorly understood. Targeting of transcription factors 
and regulatory machinery to active genomic elements in mammalian 
genomes is facilitated by these specific chromatin configurations. Chromatin 
patterns at a definite locus and the underlying regulatory processes are 
strongly related.  The combination of nucleosome positioning and dynamic 
modification of DNA and histones has a key role in gene regulation and 
guides development and differentiation. Chromatin states can influence 
transcription directly by altering the packaging of DNA to allow or prevent 
access to DNA-binding proteins, or they can modify the               
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nucleosome surface to enhance or impede recruitment of effector protein 
complexes. 
Genome-wide mapping of protein–DNA interactions and epigenetic marks is 
essential for a full understanding of transcriptional regulation and the 
functional consequences of chromatin structure. 
Chromatin Immunoprecipitation (ChIP) has been used to probe chromatin 
structure at individual loci. Later, its combination with microarrays (ChIP-
chip) and lately with next-generation sequencing has provided far more 
precise and comprehensive views of histone modification landscapes 
(Mikkelsen et al., 2007). The role of chromatin structure across diverse 
genomic features and elements can be better appreciated than in single 
regions studies. 
 
We performed chromatin immunoprecipitations of the Ash2l-, Cxxc1-, 
Men1-, Ptip- and Wdr82-eGFP targeted cell lines followed by Illumina next 
generation sequencing. The upstream qPCR results showed that the 
enrichment of our proteins of interest ranged from 20 to 100 fold more than 
the control sample. Consequent genome-wide sequencing results were 
successful for all the tagged proteins but Men1. Because of this technical 
failure, a new ChIP-seq experiment on Men1-eGFP is currently ongoing.  
In our analysis we also included the ChIP-seq data sets for Mll2-eGFP 
samples. We first examined whether the H3K4 methyltransferases had the 
ability to bind a known Mll2 target locus, the Magohb promoter (Lubitz et al., 
2007). Mll2, Ash2l and Cxxc1 showed sharp peaks on this genomic 
element. Ptip did not seem to bind Magohb promoter, whereas Wdr82 
appeared to slightly occupy the promoter. These results support our 
hypothesis that Mll2 and Setd1a complexes might function together at some 
regulatory elements. As mammals have at least six H3K4 
methyltransferases in three pairs of sister genes, consequent functional 
redundancy, or overlapping functional plasticity and compensation, is 
plausible. Furthermore, we found by Mass Spectrometry that Cxxc1, 
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described as unique component of Setd1a and Setd1b complexes, also 
immunoprecipitates Mll2 methyltransferase. This result might be the 
explanation for the presence of Cxxc1 at the Mll2 specific target gene. 
Wdr82 binding at Magohb promoter might be an indirect mechanism due to 
its association with the Setd1a complex to which Cxxc1 belongs to as well. 
 
We also analyzed how H3K4 methyltransferases cross-regulate eachother’s 
promoters. Once more, we observed that Ash2l binds the active promoters 
in all the cases, leading to the conclusion that this protein is likely located at 
all the regulatory regions of active genes containing H3K4me3 signature. 
Overall, almost all the H3K4 histone methyltransferases regulate 
eachother’s promoter, with the exception of Mll3/4 complexes, as Ptip did 
not show a considerable coverage of these regions. These results suggest 
that despite each H3K4 methyltransferase complex contains unique sets of 
proteins, which differently recruit the complex at specific loci and hence 
implying nonoverlapping functions, at least at some regulatory regions a 
functional overlapping of H3K4 methyltransferases might exist due to the 
recruitment of the complexes at common loci driven by the core of the 
complex, composed by Ash2l, Wdr5, Dpy30 and Rbbp5. As shown for 
Magohb promoter, it is likely that Setd1a and Mll2 complexes together are 
the main regulators of the H3K4 methyltransferase promoters. 
We monitored the regulation of pluripotency genes such as Nanog and Paf1 
at the promoter level. Wdr82, Cxxc1 and Ptip showed high coverage on 
both enhancer and promoter elements of the Nanog gene and on Paf1 
promoter. Moreover, we illustrated that Wdr82 and Ptip together pull down 
members of the Paf complex. It has been reported that Wdr82 interacts with 
chromatin in a manner that depends upon the monoubiquitination of H2B in 
yeast and human cells (Wu et al., 2008). In yeast the enzymatic activity for 
the monoubiquitination of H2B, however, depends on further interactions 
with the Paf complex (Takahashi and Shilatifard, 2010; Sun et al., 2002; 
Dover et al., 2002). Through a so-called “trans-tail” process, di- and 
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trimethylation of H3K4 depends on H2B ubiquitination and components of 
the Paf1 complex (Paf1, Rtf1, and Ctr9) are required for di- and 
trimethylation of H3K4. In particular, Wdr82 mediates the crosstalk between 
Set1/COMPASS and the ubiquitination complex. Therefore, similar 
dynamics in mammalian cells are plausible and in agreement with our data. 
The Paf complex component Leo1 was also immunoprecipitated by Ptip, 
suggesting that Mll3/4 complexes might participate to the same process. 
Moreover, Paf complex was shown to be involved in ES cells identity (Ding 
et al., 2009). Taken together, our results might suggest that Setd1a/b and 
Mll3/4 complexes are associated with the intricate network that regulates 
pluripotency. In support of our data it has been demonstrated that loss of 
Ptip in cultured ES cells results in H3K4 hypomethylation of Oct4 and Sox2 
promoters, causing a reduction of Oct4 mRNA and protein expression. 
Thus, ES cells undergo spontaneous differentiation toward the 
trophectoderm lineage (Kim et al., 2009). Furthermore, double conditional 
Setd1a knock out mouse ES cell lines were established in Dr. Kostantinos 
Anastassiadis group by Dr. Anita Bledau (Biotec TU, Dresden; unpublished 
data). Dr. Anita Bledau proved that by knocking out Setd1a, ES cells 
undergo severe apoptosis and do not further survive in culture. As other 
H3K4 methyltransferases are indispensable for some cell lineages, such as 
Mll1 in hematopoietic stem cells (HSCs, McMahon et al., 2007), Setd1a loss 
is deleterious for mouse ES cells. Thus, Setd1a activity and ES cells identity 
are tightly related. Setd1b instead is probably dispensable in mouse ES 
cells, as its expression level is quite low. Indeed, few peptides were 
detected by Mass Spectrometry analysis of its unique subunits. 
Nevertherless, it has been shown that Setd1b might contribute to ES cell 
state maintainance (Bilodeau et al., 2009). Mll3 is probably not involved in 
pluripotency network maintenance, because of its low expression level in 
ES cells (unpublished data). These and our results suggest that the 
continued activities of H3K4 methylation mediated by Setd1a/b and Mll4 
complexes are needed to regulate ES cell pluripotency.  
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5.5. Insights into bivalency of promoters 
 
Bernstein and colleagues remarkably observed that extended regions 
marked by H3K27me3 were also marked by H3K4me3, a histone 
modification normally associated with transcriptional activity (Bernstein et 
al., 2006). Sequential ChIP experiments confirmed that identical alleles 
were labeled by both “repressive” and “activating” chromatin modifications, 
resulting in the term “bivalent domains”. Genes within bivalent domains 
were largely repressed, to almost the same extent as genes that were 
marked by H3K27me3 alone. In contrast, genes only associated with 
H3K4me3 were highly expressed (Bernstein et al., 2006). These results 
indicate that in bivalent domains the repressive H3K27me3 state generally 
overrules the activating effect of H3K4me3. Interestingly, after 
differentiation, bivalency at promoters of transcriptional regulators was 
resolved into either regions exclusively marked by either H3K4me3 or 
H3K27me3. Based on these observations, Bernstein et al. suggested that 
bivalent domains are largely ES cell specific, serving to silence 
developmental genes while keeping them poised for activation or repression 
during later development. 
Using genome-wide epigenomic profiling strategies, several other groups 
subsequently showed that bivalency is not restricted to ES cells but also 
exists in various progenitor and differentiated cell types (Barski et al., 2007; 
Mikkelsen et al., 2007; Mohn et al., 2008; Pan et al., 2007; Zhao et al., 
2007). Mohn and coworkers observed that during lineage commitment and 
terminal differentiation existing bivalent domains are resolved while others 
are formed. The molecular mechanism responsible for the H3K4me3 mark 
deposition at bivalent promoters is still poorly understood.  In particular, how 
do the histone methyltransferase complexes act in this process? Is there 
any functional overlapping of the six mammalian H3K4 methyltransferase 
complexes at bivalent promoters? 
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Our ChIP results demonstrated that likely only Mll2 complex binds bivalent 
promoters as shown for the Sfrp5 gene. We also proved by ChIP-seq data 
clustering that the loss of Mll2 protein correlates with the loss of H3K4me3 
mark at bivalent promoters, whereas Mll1 methyltransferase loss does not 
affect H3K4 methylation at bivalent regions. Apart from that, in our ChIP-
seq data clustering we illustrated that Ash2l binds all promoters and in 
contrast, Cxxc1 did not show any coverage at bivalent promoter. Taken 
together, these results confirm that Mll1 and Setd1a/b complexes are not 
involved in the regulatory network of bivalency. We are currently including 
the Ptip data set in our analysis in order to exclude Mll3/4 complexes from a 
participation in the process. 
Moreover, comparison of Cxxc1 and Mll2 ChIP-seq clustered data further 
confirmed that Mll2 and Setd1a complexes might regulate a subset of 
promoters as a mega complex containing both H3K4 methyltransferases. 
Additionally, the protein Hcf1 has been found in both complexes by us and 
other groups (Dou et al., 2006; Vermeulen et al., 2010), supporting our 
hypothesis. Thus, only Mll2 complex would function in an exclusive manner 
at bivalent promoters.  
 
5.6. Model for regulation of chromatin state in pluripotent 
and lineage-committed cells 
 
We began our analysis of promoters by studying the distribution of the 
H3K4 methyltransferase tagged complex-specific subunits at the Magohb 
and H3K4 methyltransferase genes. Mll2 and Setd1a/b complexes showed 
a higher coverage on both loci. The cooperation between Setd1a/b and Mll2 
in a subset of promoters was further confirmed by the clustering analysis of 
our ChIP seq data, which also revealead that only Mll2 complex binds 
bivalent promoters. Moreover, we illustrated how Setd1a/b and Mll3/4 
complexes might be involved in chromatin remodeling of pluripotency gene 
promoters such as Nanog and Paf1, and in the regulation of the cell cycle. 
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We propose that Setd1a/b and Mll3/4 might function in a team that 
positively regulates pluripotency in ES cells via chromatin remodeling of 
pluripotency gene promoters and modulation of the cell cycle. Conversely, 
Setd1a/b and Mll2 complexes collaboration in a subset of promoters, 
including the pluripotency gene ones, might also contribute to a positive 
regulation of pluripotency. Indeed, depletion of Mll2 causes an increase of 
expression of Nanog (unpublished data, Dr. Helmut Hofemeister, Biotec TU, 
Dresden) and Setd1a knock out is deleterious for ES cells (unpublished 
data, Dr. Anita Bledau, Biotec TU, Dresden). In contrast, Mll2 knock out 
lines show a delay to exit self-renewal state (Lubitz et al., 2007) and no 
differentiation ability (unpublished data, Dr. Helmut Hofemeister, Biotec TU, 
Dresden). These results and the observation that only Mll2 complex seems 
to bind promoters with bivalent signature might imply that Mll2 complex is 
more important than the other HMTs for lineage commitment when the 
H3K27me3 mark is removed from bivalent promoters upon differentiation 
stimuli (Fig. 37).  
 
Fig. 37. Model for regulation of pluripotency and differentiation mediated by H3K4 
methyltransferases. Setd1a/b is either coupled with Mll3/4 complexes or Mll2 complex to positively 
regulate pluripotency. Mll2 complex alone is important for differentiation. (+) Positive regulation. 
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6. Summary 
Genetic and epigenetic mechanisms ensure that complex developmental 
programs are correctly executed. One important post-translational 
modification that regulates transcriptional outcomes, genome integrity and 
cellular identity is histone 3 lysine 4 methylation. 
The mammalian genome harbors six different H3K4 histone 
methyltransferases (Setd1a, Setd1b, Mll1-4), close homologues of the S. 
cerevisiae and S. pombe Set1 proteins that function in complexes called 
COMPASS. Set1C/COMPASS and Mll function in multi-protein complexes 
that share four core components (Wdr5, Rbbp5, Ash2L and Dpy30) and 
have few complex-specific subunits.  
This study was focused on development of GFP/YFP tagging strategies for 
BAC transgenesis and gene targeting in mouse embryonic stem cells in 
order to better understand the complex mechanism underlying the histone 3 
lysine 4 methylation.  
Four complex-specific subunits Men1 (unique to Mll1 and Mll2 complexes), 
Ptip (specific for Mll3 and Mll4 complexes), Cxxc1 and Wdr82 (exclusive for 
Setd1a and Setd1b complex), and one shared complex component (Ash2l) 
were tagged with a multipurpose GFP tag by recombineering and 
expressed in mouse ES cells in BAC transgenic and targeted formats. 
Western Blot and confocal microscopy proved correct expression and 
localization of the tagged proteins. BAC transgenic lines did not show to 
have a high number of functional integration. Thus, BAC transgenesis might 
be a faster alternative to gene targeting. 
Interestingly, Ptip appeared to bind chromatin during mitosis. Ptip 
involvement in cell cycle regulation was subsequently demonstrated by 
interaction with cell cycle related proteins such as Terf1 and Terf2. 
Conversely, Wdr82 might have a role in the regulation of chromatin 
structure during the transition from mitosis into interphase via interaction 
with the PTW/PP1 phosphatase complex. 
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Furthermore, Mass Spectrometry analysis showed that all the examined 
tagged proteins were able to immunoprecipitate their known protein 
interactor plus a certain number of newly discovered ones. Particularly, 
Bod1l was identified as mouse ortholog of the yeast Shg1, subunit of 
Set1C. Bod1l was tagged with mVenus/YFP for a BAC transgenesis 
purpose and once expressed in mouse ES cells it showed to 
immunoprecipitate the core component Ash2l. In addition, Bod1l seems to 
be regulated by the H3K4 methyltransferases at promoter level. 
We illustrated how Setd1a/b and Mll3/4 complexes might be involved in 
pluripotency state maintenance in ES cells through protein interaction with 
the Paf complex and regulation of promoters of pluripotency factors. 
ChIP-seq data have partly fulfilled the lack of information on the intricate 
machinery regulating bivalency at promoter regions. Indeed, Mll2 complex 
seems to be exclusively involved in this process, although it may function 
together with Setd1a complex in a subset of promoters.  
In general our tagged strategies was successful and efficient and the tag 
did not show to neither alter the localization or the function of the analyzed 
proteins. Application of our tagging methods provided a powerful tool to 
investigate H3K4 methyltransferase complexes function and structure. 
Overall, our results added novel insights into the composition of H3K4 
methyltransferase complexes, bivalency of promoters and regulation of cell 
cycle and pluripotency network. 
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7. Abbreviations 
 
aa aminoacid 
ATP Adenosine-5'-triphosphate 
BAC Bacterial Artificial Chromosome 
BROMO Bromodomain 
C-terminus / N-terminus Carboxy-terminus / Amino-terminus 
ChIP Chromatin ImmunoPrecipitation 
ChIP-seq Chromatin ImmunoPrecipitation-
sequencing 
CHROMO Chromodomain 
COMPASS Complex Associated with Set1 
CpG C-phosphate-G 
CTD Carboxy Terminal Domain 
ddH2O distilled water 
DNA desoxyribonucleic acid 
DNMT DNA MethylTransferase 
E.Coli Escherichia Coli 
EDTA ethylene diamine tetra acetic acid 
EpiSCs Epiblast-derived Stem Cells 
ES cells embryonic stem cells 
et al.  and others 
g relative centrifugal force in units of 
gravity 
GFP Green Fluorescent Protein 
h hours 
H Histone 
HMT Histone MethylTransferase 
HSCs Hematopoietic Stem Cells  
ICM Inner cell mass 
IP ImmunoPrecipitation 
iPSCs Induced Pluripotent Stem Cells 
IRES Internal Ribosome Entry Site 
K Lysine 
kb Kilobase 
kDa kilo Dalton 
ko knock out 
M Molar 
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mA milliAmpere 
MAX 13.000 rpm 
me1/2/3 methylation (mono/di/tri) 
MEFs Mouse Embryonic Fibroblasts 
min minute(s) 
Mll mouse Mixed lineage leukemia 
mRNA messenger RNA 
MS Mass  Spectrometry 
NR Nuclear Receptor 
ON Over Night 
PcG polycomb group proteins 
PCR polymerase chain reaction 
PGK  PhosphoGlycerate Kinase 
PhoRC Pleiohomeotic repressive complex 
PRC Polycomb repressive complex 
qPCR quantitative real time-PCR 
RNA RiboNucleic Acid 
rpm rounds per minute 
RT Room Temperature 
s/sec seconds 
TAP Tandem Affinity Purification 
TRR Drosophila trithorax related gene / 
protein 
TRX Drosophila trithorax gene / protein 
TrxG Trithorax Group proteins 
V Volt 
wt wild type 
YFP Yellow Fluorescent Protein 
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